image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
c4175b43e2f9a1e008a5f0febd20e7cbed6a346ce32d1d6712716ff9cb83e061.png | complex | <table><tr><td></td><td colspan="3">Yale University cohort</td><td></td></tr><tr><td>Variable</td><td>No. of patients (%) (n = 651)</td><td>HR</td><td>95% CI</td><td><i>P</i>*</td></tr><tr><td>Age at diagnosis</td><td>645 (99.1)</td><td>0.999</td><td>0.988-1.009</td><td>0.890</td></tr><tr><td> Unknown/missing</td><td>6... | <table><tr><td></td><td colspan="3">Yale University cohort</td><td></td></tr><tr><td>Variable</td><td>No. of patients (%) (n = 651)</td><td>HR</td><td>95% CI</td><td>P*</td></tr><tr><td>Age at diagnosis</td><td>645 (99.1)</td><td>0.999</td><td>0.988-1.009</td><td>0.890</td></tr><tr><td>Unknown/missing</td><td>6 (0.9)</... | <table><tr><td>nown/missing</td><td> (4.0)</td><td></td><td></td><td></td></tr><tr><td>Nuclear grade</td><td></td><td></td><td></td><td></td></tr><tr><td>Small/uniform nuclei</td><td>113 (17.4)</td><td>1.000</td><td></td><td>0.0007</td></tr><tr><td>Intermediate nuclei</td><td>315 (48.4)</td><td>1.231</td><td>0.854-1.81... |
6187edbb2d4504573a032357c49b973b755b6b2c38f85c5da358d7e41d7a75e6.png | complex | <table><tr><td>Study groups</td><td>N</td><td>Mean</td><td>SD</td><td>P-value</td></tr><tr><td>Live Demonstration</td><td>26</td><td>6.69</td><td>1.4</td><td rowspan="3">.864*</td></tr><tr><td>Procedural Video</td><td>23</td><td>6.78</td><td>2.1</td></tr><tr><td>Total</td><td>49</td><td>6.73</td><td>1.8</td></tr></tabl... | <table><tr><td>Study groups</td><td>N</td><td>Mean</td><td>SD</td><td>P-value</td></tr><tr><td>Live Demonstration</td><td>26</td><td>6.69</td><td>1.4</td><td>.864*</td></tr></table> | <table><tr><td>Study groups</td><td>N</td><td>Mean</td><td>SD</td><td>P-value</td></tr><tr><td>Procedural Video</td><td>23</td><td>6.78</td><td>2.1</td><td rowspan="2">.864*</td></tr><tr><td>Total</td><td>49</td><td>6.73</td><td>1.8</td></tr></table> |
9de0eb28e3611efc1f374db62bc0c3c94b28d27dc020ec8cf6c4f8217f621250.png | simple | <table><tr><td>Resource</td><td>Connectivity Comments</td><td>Reference</td></tr><tr><td>BindingDB</td><td>Comprehensive ligand-target database, we now cross-reference selected patent extractions from this source</td><td>(43)</td></tr><tr><td>ChEMBL and UniChem</td><td>Inclusion of our target protein pointers and a ChE... | <table><tr><td>Resource</td><td>Connectivity Comments</td><td>Reference</td></tr><tr><td>BindingDB</td><td>Comprehensive ligand-target database, we now cross-reference selected patent extractions from this source</td><td>(43)</td></tr><tr><td>ChEMBL and UniChem</td><td>Inclusion of our target protein pointers and a ChE... | <table><tr><td>Resource</td><td>Connectivity Comments</td><td>Reference</td></tr><tr><td>IMGT/mAb-DB</td><td>Pointers to provenanced sequences for clinical antibodies, target interactions, display tools and residue numbering system</td><td>(50)</td></tr><tr><td>MEROPS</td><td>Feature details, classification, ligand map... |
081e9128359490aef10a1615fa9b5e50f32b2b55afe343c80ce0cd6ab5b1794e.png | simple | <table><tr><td>Chr</td><td>MS</td><td>AI</td><td>DA</td><td>KA</td><td>NY</td><td>SNP</td><td>AI</td><td>DA</td><td>KA</td></tr><tr><td>1</td><td>D01S0023</td><td>21.60</td><td>41.65</td><td>12.18</td><td>14.59</td><td>C01R0052</td><td>21.53</td><td>47.08</td><td>13.43</td></tr><tr><td>3</td><td>D03S0127</td><td>30.32<... | <table><tr><td>Chr</td><td>MS</td><td>AI</td><td>DA</td><td>KA</td><td>NY</td><td>SNP</td><td>AI</td><td>DA</td><td>KA</td></tr><tr><td>1</td><td>D01S0023</td><td>21.60</td><td>41.65</td><td>12.18</td><td>14.59</td><td>C01R0052</td><td>21.53</td><td>47.08</td><td>13.43</td></tr></table> | <table><tr><td>3</td><td>D03S0127</td><td>30.32</td><td>37.70</td><td>26.91</td><td>30.16</td><td>C03R280</td><td></td><td>35.19</td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td>C03R281</td><td>28.93</td><td>35.11</td><td>28.86</td></tr><tr><td>5</td><td>D05S0172</td><td></td><td>8.52</td... |
2d2dfcb6777cfc1889f42a3460c3c27a488331061bba9f95dbf3a81bf58f3c07.png | complex | <table><tr><td>Multivariate Cox regression</td><td></td><td></td><td></td><td></td></tr><tr><td>Factor</td><td><i>P</i></td><td>HR</td><td colspan="2">95% CI</td></tr><tr><td></td><td></td><td></td><td>Lower</td><td>Upper</td></tr><tr><td>INSS Stage (1-3, 4S vs 4)</td><td>0.002</td><td>7.15</td><td>2.08</td><td>24.64</... | <table><tr><td>Multivariate Cox regression</td><td></td></tr><tr><td>Factor</td><td>P</td></tr><tr><td></td><td></td></tr><tr><td>INSS Stage (1-3, 4S vs 4)</td><td>0.002</td></tr><tr><td>NB-hypo</td><td>0.007</td></tr><tr><td>Age (< 1y vs > 1y)</td><td>0.801</td></tr><tr><td>MYCN (normal vs amplified)</td><td>0.671</td... | <table><tr><td></td><td></td><td></td></tr><tr><td>HR</td><td colspan="2">95% CI</td></tr><tr><td></td><td>Lower</td><td>Upper</td></tr><tr><td>7.15</td><td>2.08</td><td>24.64</td></tr><tr><td>2.73</td><td>1.31</td><td>5.69</td></tr><tr><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td></tr></table> |
2d2b63092d79ee33c44baba7b50c861791200d0fc9d473b2fd3c068df2f59b5f.png | complex | <table><tr><td rowspan="2"> </td><td rowspan="2"> </td><td colspan="2">All</td><td colspan="2">Control group</td><td colspan="2">Intervention group</td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Study group</td><td> </td><td>604</td><td>100</td><td>242</td><td>40.1</td><td>362</td... | <table><tr><td rowspan="2"></td><td rowspan="2"></td><td colspan="2">All</td><td colspan="2">Control group</td><td colspan="2">Intervention group</td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Study group</td><td></td><td>604</td><td>100</td><td>242</td><td>40.1</td><td>362</td><t... | <table><tr><td>e</td><td></td><td>1</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>19</td><td>131</td><td>21.8</td><td>65</td><td>27.0</td><td>66</td><td>18.4</td></tr><tr><td></td><td>20</td><td>452</td><td>75.3</td><td>170</td><td>70.5</td><td>282</td><td>78.6</td></tr><tr><td></td><td>21</td>... |
b83d87b7c7806b92640e600d9dafc301eaf30f6759874d06fe25a962f46e9737.png | complex | <table><tr><td>(n = 593)</td><td>One-factor model</td><td colspan="2">Two-factor model</td><td colspan="3">Three-factor model</td></tr><tr><td>Sensation</td><td>Sensitivity</td><td>Pleasant</td><td>Unpleasant</td><td>Pleasant</td><td>Unpleasant</td><td>Buzz</td></tr><tr><td>Cough</td><td>0.27</td><td>−0.16</td><t... | <table><tr><td>(n = 593)</td><td>One-factor model</td><td colspan="2">Two-factor model</td><td colspan="3">Three-factor model</td></tr><tr><td>Sensation</td><td>Sensitivity</td><td>Pleasant</td><td>Unpleasant</td><td>Pleasant</td><td>Unpleasant</td><td>Buzz</td></tr><tr><td>Cough</td><td>0.27</td><td>−0.16</td><td>0.52... | <table><tr><td>(n = 593)</td><td>One-factor model</td><td colspan="2">Two-factor model</td><td colspan="3">Three-factor model</td></tr><tr><td>Sensation</td><td>Sensitivity</td><td>Pleasant</td><td>Unpleasant</td><td>Pleasant</td><td>Unpleasant</td><td>Buzz</td></tr><tr><td>High</td><td>.59</td><td>.74</td><td></td><td... |
98463272a7b8a18457595e6f6ded1fbb57cf646181c0d2ec675e696468dfc680.png | simple | <table><tr><td>Author (year) of published PCR assay</td><td>PCR target</td><td>PCR technique</td><td>Amplicon size (bp)</td><td>Zika virus lineage analytical</td><td>Zika virus lineage field</td><td>No. of human patients tested in studies</td><td>Sample types positive in field</td></tr><tr><td>Lanciotti et al. (2008)<s... | <table><tr><td>Author (year) of published PCR assay</td><td>PCR target</td><td>PCR technique</td><td>Amplicon size (bp)</td><td>Zika virus lineage analytical</td><td>Zika virus lineage field</td><td>No. of human patients tested in studies</td><td>Sample types positive in field</td></tr><tr><td>Lanciotti et al. (2008)43... | <table><tr><td>Tappe et al. (2014)19</td><td>Zika virus NS3</td><td>Hydrolysis probe</td><td>94</td><td>Asian</td><td>Asian</td><td>519–22,25</td><td>Serum</td></tr><tr><td>Faye et al. (2008)52</td><td>Zika virus E</td><td>Conventional</td><td>364</td><td>African</td><td>Asian</td><td>> 15 (combined set)53,54</td><td>S... |
77849470f34ab849a00e615494c9a2958424d06465c7ea17d42063007e6d0689.png | simple | <table><tr><td>Explanatory variable</td><td>OR</td><td>95%CI</td><td>P value</td></tr><tr><td>Presence of C allele in genotype at rs3173798 (Yes=1, No=0)</td><td>0.28</td><td>0.12–0.67</td><td>0.0043</td></tr><tr><td>Age (years)</td><td>0.97</td><td>0.93–1.02</td><td>0.27</td></tr><tr><td>Gender (female=1, ... | <table><tr><td>Explanatory variable</td><td>OR</td><td>95%CI</td><td>P value</td></tr><tr><td>Presence of C allele in genotype at rs3173798 (Yes=1, No=0)</td><td>0.28</td><td>0.12–0.67</td><td>0.0043</td></tr><tr><td>Age (years)</td><td>0.97</td><td>0.93–1.02</td><td>0.27</td></tr><tr><td>Gender (female=1, male=0)</td>... | <table><tr><td>Explanatory variable</td><td>OR</td><td>95%CI</td><td>P value</td></tr><tr><td>GLD (μm)</td><td>1</td><td>1.00–1.00</td><td>0.88</td></tr></table> |
07bef33c2cc04db0c30aece8ad26d1d5d0ae5e7fab3d704914055a1285ae14b1.png | complex | <table><tr><td rowspan="3">Age group</td><td colspan="6">1990</td><td colspan="6">2015</td></tr><tr><td colspan="3">Global</td><td colspan="3">Brazil</td><td colspan="3">Global</td><td colspan="3">Brazil</td></tr><tr><td>Rate</td><td colspan="2">95% UI</td><td>Rate</td><td colspan="2">95% UI</td><td>Rate</td><td colspa... | <table><tr><td rowspan="3">Age group</td><td colspan="6">1990</td><td colspan="6">2015</td></tr><tr><td colspan="3">Global</td><td colspan="3">Brazil</td><td colspan="3">Global</td><td colspan="3">Brazil</td></tr><tr><td>Rate</td><td colspan="2">95% UI</td><td>Rate</td><td colspan="2">95% UI</td><td>Rate</td><td colspa... | <table><tr><td>45–49</td><td>1022.3</td><td>(827.8</td><td>1264.5)</td><td>1246.0</td><td>(1037.0</td><td>1512.3)</td><td>1241.7</td><td>(983.4</td><td>1556.5)</td><td>1190.9</td><td>(944.3</td><td>1490.3)</td></tr><tr><td>50–54</td><td>1435.9</td><td>(1175.5</td><td>1747.8)</td><td>1892.2</td><td>(1591.6</td><td>2277.... |
19388fced408bffa4c9c9c0022ab85a14f10358cac4aab545cc730ec35257e68.png | complex | <table><tr><td></td><td colspan="3">The GP and the patient are a well-functioning team (<i>n</i> = 270)</td></tr><tr><td></td><td>OR</td><td>95% CI</td><td><i>p</i>-value</td></tr><tr><td colspan="4">Age</td></tr><tr><td> 16–39</td><td>1.30</td><td>0.63–2.71</td><td>0.471</td></tr><tr><td> 40–59<sup>a... | <table><tr><td></td><td colspan="3">The GP and the patient are a well-functioning team (n = 270)</td></tr><tr><td></td><td>OR</td><td>95% CI</td><td>p-value</td></tr><tr><td colspan="4">Age</td></tr><tr><td>16–39</td><td>1.30</td><td>0.63–2.71</td><td>0.471</td></tr><tr><td>40–59a</td><td>1.00</td><td>–</td><td>–</td><... | <table><tr><td>Primary</td><td>0.56</td><td>0.19–1.69</td><td>0.306</td></tr><tr><td>High school</td><td>1.69</td><td>0.77–3.70</td><td>0.192</td></tr><tr><td>University 1–4 yearsa</td><td>1.00</td><td>–</td><td>–</td></tr><tr><td>University 5 years +</td><td>0.53</td><td>0.25–1.13</td><td>0.101</td></tr><tr><td colspa... |
e362f246ab0037323067d9923df79a0a20fd614831f87c2346ca66f9ca052304.png | simple | <table><tr><td>Age group</td><td>Patients, no.</td><td>%</td></tr><tr><td>Infant</td><td>9</td><td>0</td></tr><tr><td>Child</td><td>12</td><td>0</td></tr><tr><td>Adolescent</td><td>4</td><td>0</td></tr></table> | <table><tr><td>Age group</td><td>Patients, no.</td><td>%</td></tr></table> | <table><tr><td>Infant</td><td>9</td><td>0</td></tr><tr><td>Child</td><td>12</td><td>0</td></tr><tr><td>Adolescent</td><td>4</td><td>0</td></tr></table> |
f124df5d8fddbc0fa6b32d2cdc4da06b58d2109f04a63f60116ee797191e528c.png | simple | <table><tr><td></td><td>Calcium score zero (<i>N</i> = 239)</td><td>Calcium score abnormal (<i>N</i> = 103)</td><td><i>P</i> value</td></tr><tr><td>Age, years</td><td>47.0 (6.4)</td><td>52.6 (6.6)</td><td><0.001</td></tr><tr><td>Gender, female %</td><td>66 (27.6)</td><td>11 (10.6)</td><td></td></tr><tr><td>Height, c... | <table><tr><td></td><td>Calcium score zero (N = 239)</td><td>Calcium score abnormal (N = 103)</td><td>P value</td></tr><tr><td>Age, years</td><td>47.0 (6.4)</td><td>52.6 (6.6)</td><td><0.001</td></tr><tr><td>Gender, female %</td><td>66 (27.6)</td><td>11 (10.6)</td><td></td></tr><tr><td>Height, cm</td><td>165.9 (7.5)</t... | <table><tr><td></td><td>Calcium score zero (N = 239)</td><td>Calcium score abnormal (N = 103)</td><td>P value</td></tr><tr><td>Weight, kg</td><td>65.9 (11.3)</td><td>68.9 (10.1)</td><td>0.008</td></tr><tr><td>BMI, Kg/m2</td><td>23.8 (3.1)</td><td>24.4 (2.7)</td><td>0.013</td></tr><tr><td>Waist, cm</td><td>81.4 (9.1)</t... |
432f2974ff0e323790e429512471a58a03f4a38e5f0e49a80f57f08608f7ed16.png | complex | <table><tr><td></td><td colspan="3">Week 1<sup>A</sup></td><td colspan="3">Week 2<sup>A</sup></td><td colspan="2"><i>P</i></td></tr><tr><td></td><td>Control</td><td>Canola</td><td>Sunflower</td><td>Control</td><td>Canola</td><td>Sunflower</td><td>Trt<sup>B</sup></td><td>Trt*wk<sup>C</sup></td></tr><tr><td>Cows (n)</td>... | <table><tr><td></td><td colspan="3">Week 1A</td><td colspan="3">Week 2A</td><td colspan="2">P</td></tr><tr><td></td><td>Control</td><td>Canola</td><td>Sunflower</td><td>Control</td><td>Canola</td><td>Sunflower</td><td>TrtB</td><td>Trt*wkC</td></tr><tr><td>Cows (n)</td><td>5</td><td>5</td><td>5</td><td>6</td><td>5</td><... | <table><tr><td>LH-Peak-time (min) E</td><td>32.50 ± 13.26</td><td>48.00 ± 13.78</td><td>22.50 ± 10.27</td><td>81.37 ± 21.53</td><td>101.63 ± 21.53</td><td>63.37 ± 21.53</td><td>0.48</td><td>0.74</td></tr><tr><td>AUC (ng/mL per 4 h) F</td><td>41.52 ± 27.39</td><td>84.65 ± 29.26</td><td>48.51 ± 25.38</td><td>197.26 ± 26.... |
baad41387d9d9bb0c955d600550056153811b0418b38b66115512f5dfb194530.png | simple | <table><tr><td>Patient</td><td>Breed</td><td>Age</td><td>Sex</td><td>Activity</td><td>Laminitis Stage</td><td>Venography Stage</td><td>Prognosis (before Treatment)</td></tr><tr><td>CASE 1</td><td>QUARTER HORSE</td><td>18</td><td>F</td><td>MARE</td><td>BILATERAL ROTATION</td><td>4</td><td>POOR</td></tr><tr><td>CASE 2</t... | <table><tr><td>Patient</td><td>Breed</td><td>Age</td><td>Sex</td><td>Activity</td><td>Laminitis Stage</td><td>Venography Stage</td><td>Prognosis (before Treatment)</td></tr><tr><td>CASE 1</td><td>QUARTER HORSE</td><td>18</td><td>F</td><td>MARE</td><td>BILATERAL ROTATION</td><td>4</td><td>POOR</td></tr><tr><td>CASE 2</t... | <table><tr><td>Patient</td><td>Breed</td><td>Age</td><td>Sex</td><td>Activity</td><td>Laminitis Stage</td><td>Venography Stage</td><td>Prognosis (before Treatment)</td></tr><tr><td>CASE 7</td><td>DUTCH WARMBLOOD</td><td>21</td><td>F</td><td>PLEASURE</td><td>BILATERAL SINKING AND ROTATION</td><td>3-4</td><td>POOR</td></... |
e171d0a2ee782d9982764d34e0670ccd4c7929693ebf6fdf98cf0609f5bee55d.png | simple | <table><tr><td>Scales</td><td>N</td><td>Mean</td><td>SD</td><td>Min.</td><td>Q1</td><td>Median</td><td>Q3</td><td>Max.</td><td><i>P</i>-value</td></tr><tr><td>HSQS/EPM (1st administration)</td><td>86</td><td>74.6</td><td>4.6</td><td>60.0</td><td>72.0</td><td>75.5</td><td>78.0</td><td>86.4</td><td>0.005<sup>1</sup></td>... | <table><tr><td>Scales</td><td>N</td><td>Mean</td><td>SD</td><td>Min.</td><td>Q1</td><td>Median</td><td>Q3</td><td>Max.</td><td>P-value</td></tr></table> | <table><tr><td>HSQS/EPM (1st administration)</td><td>86</td><td>74.6</td><td>4.6</td><td>60.0</td><td>72.0</td><td>75.5</td><td>78.0</td><td>86.4</td><td>0.0051</td></tr><tr><td>SEVQUAL scale</td><td>86</td><td>76.7</td><td>5.7</td><td>60.0</td><td>73.0</td><td>78.0</td><td>78.0</td><td>99.0</td><td></td></tr></table> |
384c4efa3ab1654da840069f186923ee5e400fd50219d3264ca49dafc756a8df.png | complex | <table><tr><td colspan="2"></td><td colspan="4">Patients’ characteristics</td></tr><tr><td>Gender</td><td></td><td>Age</td><td>Weight</td><td>Height</td><td>BMI</td></tr><tr><td rowspan="5">Females</td><td><i>n</i></td><td>66</td><td>66</td><td>66</td><td>66</td></tr><tr><td>Mean (SD)</td><td>62.8 (9.28)</td><td>... | <table><tr><td colspan="2"></td><td>Patients’ characteristics</td></tr><tr><td>Gender</td><td></td><td>Age</td></tr><tr><td rowspan="5">Females</td><td>n</td><td>66</td></tr><tr><td>Mean (SD)</td><td>62.8 (9.28)</td></tr><tr><td>95 % CI</td><td>60.5, 65.0</td></tr><tr><td>Median</td><td>63.2</td></tr><tr><td>Range</td>... | <table><tr><td colspan="3">Patients’ characteristics</td></tr><tr><td>Weight</td><td>Height</td><td>BMI</td></tr><tr><td>66</td><td>66</td><td>66</td></tr><tr><td>77.4 (18.28)</td><td>166.6 (5.29)</td><td>27.7 (6.01)</td></tr><tr><td>72.9, 81.9</td><td>165.3, 167.9</td><td>26.3, 29.2</td></tr><tr><td>74.0</td><td>167.5... |
7af61e0fba35c02ef730636d2417ade80ce72212c6233cc51789179cee20affa.png | complex | <table><tr><td rowspan="2">Clinical and epidemiological characteristic</td><td colspan="2">Another malignancy</td><td rowspan="2"><i>P</i></td></tr><tr><td>Postiodine<i>N</i> = 7 (46.66%)</td><td>Preiodine<i>N</i> = 8 (53.33%)</td></tr><tr><td>Males <i>N</i> (%)</td><td>4 (57.14)</td><td>3 (37.5)</td><td>0.6193</td></t... | <table><tr><td rowspan="2">Clinical and epidemiological characteristic</td><td colspan="2">Another malignancy</td><td rowspan="2">P</td></tr><tr><td>PostiodineN = 7 (46.66%)</td><td>PreiodineN = 8 (53.33%)</td></tr><tr><td>Males N (%)</td><td>4 (57.14)</td><td>3 (37.5)</td><td>0.6193</td></tr><tr><td>Age at thyroidecto... | <table><tr><td>Classic nonpapilliferous histological type N (%)</td><td>3 (42.85)</td><td>2 (25)</td><td>0.6084</td></tr></table> |
8a8a2ee59494752736aa72444ff5616f3de3c2c435b2f46f904d193213222c05.png | complex | <table><tr><td colspan="2">CONSENSUS CRITERIA FOR DEMENTIA CASE ASCERTAINMENT</td></tr><tr><td>PROBABLE DEMENTIA</td><td>POSSIBLE DEMENTIA</td></tr><tr><td>ANY of the following (without opposing evidence from same/other source):- dementia diagnosis on death certificate (any part)- dementia diagnosed on clinical review ... | <table><tr><td colspan="2">CONSENSUS CRITERIA FOR DEMENTIA CASE ASCERTAINMENT</td></tr><tr><td>PROBABLE DEMENTIA</td><td>POSSIBLE DEMENTIA</td></tr></table> | <table><tr><td>ANY of the following (without opposing evidence from same/other source):- dementia diagnosis on death certificate (any part)- dementia diagnosed on clinical review (ICD-10/DSM-IV)- dementia diagnosis in electronic general medical records (Trak)- dementia diagnosis in electronic psychiatric records (PIMS)... |
2a74453c80b60f5b2d34a65f6eb9052d58f2693e7e7a509703d041f76d19526a.png | simple | <table><tr><td>Isolate</td><td>ST <sup>1</sup></td><td>CC <sup>2</sup></td><td>LIPI1</td><td>LIPI3</td><td>LIPI4</td><td>InlA </td><td>SSI-1</td></tr><tr><td>MQ130026</td><td>ST-1</td><td>CC1</td><td>+ <sup>3</sup></td><td>+</td><td>− <sup>4</sup></td><td>+ <sup>5</sup></td><td>−</td></tr><tr><td>L970</td><... | <table><tr><td>Isolate</td><td>ST 1</td><td>CC 2</td><td>LIPI1</td><td>LIPI3</td><td>LIPI4</td><td>InlA</td><td>SSI-1</td></tr><tr><td>MQ130026</td><td>ST-1</td><td>CC1</td><td>+ 3</td><td>+</td><td>− 4</td><td>+ 5</td><td>−</td></tr><tr><td>L970</td><td>ST-1</td><td>CC1</td><td>+</td><td>+</td><td>−</td><td>+</td><td>... | <table><tr><td>MQ150007</td><td>ST-431</td><td>CC101</td><td>+</td><td>−</td><td>−</td><td>+</td><td>−</td></tr></table> |
46ee1776e9ce2f096ea20d70c48ad5696654006da7f728f6cc64c53724fa58a2.png | simple | <table><tr><td>Variable</td><td>All patients (n = 102)</td><td>Group 1 (n = 48)</td><td>Group 2 (n = 54)</td></tr><tr><td>FEV<sub>1</sub></td><td>50 (0.84 [0.70;0.98])<sup>a</sup></td><td>31 (1.08 [0.70;1.45])<sup>a</sup></td><td>18 (0.67 [0.46;0.88])<sup>a</sup></td></tr><tr><td>BR</td><td>12 (−0.62 [−0.82... | <table><tr><td>Variable</td><td>All patients (n = 102)</td></tr><tr><td>FEV1</td><td>50 (0.84 [0.70;0.98])a</td></tr><tr><td>BR</td><td>12 (−0.62 [−0.82;-0.42])a</td></tr><tr><td>VE/VCO2 peak</td><td>5 (−1.13 [−1.56;-0.69])a</td></tr></table> | <table><tr><td>Group 1 (n = 48)</td><td>Group 2 (n = 54)</td></tr><tr><td>31 (1.08 [0.70;1.45])a</td><td>18 (0.67 [0.46;0.88])a</td></tr><tr><td>6 (−0.36 [−0.68;-0.04])b</td><td>35 (−0.85 [−1.10;-0.59])a</td></tr><tr><td>15 (−0.95 [−1.41;-0.48])c</td><td>6 (−1.52 [−2.22;-0.82])a</td></tr></table> |
15b7a6fbbee3049a5e8e6f31d2dde1cfde7134156e5f788a232b5f3093b998cd.png | simple | <table><tr><td>(1) Memory</td><td>(2) Language</td><td>(3) Perceptual</td><td>(4) Visuospatial</td><td>(5) Calculation</td></tr><tr><td>Rey immediate recall</td><td>Semantic fluency </td><td>VOSP X-detection</td><td>Barrage</td><td>Additions</td></tr><tr><td>Rey delayed recall</td><td>Phonological fluency</td><td>Bento... | <table><tr><td>(1) Memory</td><td>(2) Language</td><td>(3) Perceptual</td><td>(4) Visuospatial</td></tr><tr><td>Rey immediate recall</td><td>Semantic fluency</td><td>VOSP X-detection</td><td>Barrage</td></tr><tr><td>Rey delayed recall</td><td>Phonological fluency</td><td>Benton</td><td>Spatial span</td></tr><tr><td>Rec... | <table><tr><td>(5) Calculation</td></tr><tr><td>Additions</td></tr><tr><td>Subtractions</td></tr><tr><td></td></tr><tr><td></td></tr></table> |
149db96c33c1f66aa82e37de920bbb8f6bd8c9e307e9c47be019c539684e9ec3.png | complex | <table><tr><td rowspan="3" colspan="2">Change in response variables</td><td colspan="6">Explanatory variables</td></tr><tr><td rowspan="2">Dose of tofacitinib<sup>a</sup></td><td colspan="5">Lymphocyte sub-populations</td></tr><tr><td>T (CD3<sup>+</sup>)</td><td>T<sub>H</sub>(CD3<sup>+</sup>/CD4<sup>+</sup>)</td><td>T<... | <table><tr><td rowspan="3" colspan="2">Change in response variables</td><td colspan="3">Explanatory variables</td></tr><tr><td rowspan="2">Dose of tofacitiniba</td><td colspan="2">Lymphocyte sub-populations</td></tr><tr><td>T (CD3+)</td><td>TH(CD3+/CD4+)</td></tr><tr><td rowspan="3">CMV viral load, copies/500 ng total ... | <table><tr><td colspan="3">Explanatory variables</td></tr><tr><td colspan="3">Lymphocyte sub-populations</td></tr><tr><td>TC(CD3+/CD8+)</td><td>B (CD19+)</td><td>NK (CD16+/CD56+)</td></tr><tr><td>1</td><td>1</td><td>1</td></tr><tr><td>0.68</td><td>0.00</td><td>0.03</td></tr><tr><td>0.4112</td><td>0.9925</td><td>0.8592<... |
8d2eb63b44adbef2f2e21434c3caf7c0e32e9a6de38db60084d0c4dbf9db86b1.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">IOP (mmHg)</td><td></td><td colspan="2">OPP (mmHg)</td><td></td></tr><tr><td>Affected Eye</td><td>Unaffected Eye</td><td><i>P</i> value*</td><td>Affected Eye</td><td>Unaffected Eye</td><td><i>P</i> value*</td></tr><tr><td>T1</td><td>16.6 ± 3.4 (10.5–23.3)</td><... | <table><tr><td rowspan="2"></td><td colspan="2">IOP (mmHg)</td></tr><tr><td>Affected Eye</td><td>Unaffected Eye</td></tr><tr><td>T1</td><td>16.6 ± 3.4 (10.5–23.3)</td><td>15.6 ± 2.9 (9.5–20.6)</td></tr><tr><td>T2</td><td>17.8 ± 3.5 (11.6–28.1)</td><td>17.4 ± 3.2 (11.8–24.1)</td></tr><tr><td>T3</td><td>20.2 ± 4.2 (13.8–... | <table><tr><td></td><td colspan="2">OPP (mmHg)</td><td></td></tr><tr><td>P value*</td><td>Affected Eye</td><td>Unaffected Eye</td><td>P value*</td></tr><tr><td>0.055</td><td>50.1 ± 9.9 (35.4–77.6)</td><td>51.1 ± 11.0 (33.4–78.3)</td><td>0.055</td></tr><tr><td>0.327</td><td>65.7 ± 12.4 (47.6–92.2)</td><td>66.2 ± 12.5 (4... |
b54a3d038c17fa9edd63aa6bddbe672346935860bbb66497556aa40c4182852a.png | simple | <table><tr><td>#</td><td>Nugget Topic</td><td>Nugget Content (3rd ed.)</td></tr><tr><td>6.</td><td><i>Pharmacological management of neuropathic pain</i></td><td>Use a step-wise evidence-based protocol for the management of neuropathic pain in SCI, and review pain management annually.</td></tr><tr><td>10.</td><td><i>Die... | <table><tr><td>#</td><td>Nugget Topic</td><td>Nugget Content (3rd ed.)</td></tr><tr><td>6.</td><td>Pharmacological management of neuropathic pain</td><td>Use a step-wise evidence-based protocol for the management of neuropathic pain in SCI, and review pain management annually.</td></tr><tr><td>10.</td><td>Diet & fluid ... | <table><tr><td>14.</td><td>Pharmacological management of UTI in SCI</td><td>There is no superior agent or class of antibiotics for UTIs in spinal cord injury. Recurrent UTIs should be treated as complicated infections, and treatment must be customized to the patient and the infecting organism.</td></tr><tr><td>15.</td>... |
393be005d439d22c4e3dbdccfc61de8f227335602f79123f14fa4e88de01798f.png | simple | <table><tr><td>CNTs</td><td>Hydroxyl Content % (<i>w</i>/<i>w</i>)</td><td>Carboxyl Content % (<i>w</i>/<i>w</i>)</td><td>Diameter (nm)</td><td>Length (μm)</td><td>SSA (m<sup>2</sup>/g)</td><td>PC Sets</td><td>PC Names</td></tr><tr><td>F1</td><td>_</td><td>_</td><td>10–20</td><td>30–100</td><td>>165... | <table><tr><td>CNTs</td><td>Hydroxyl Content % (w/w)</td><td>Carboxyl Content % (w/w)</td><td>Diameter (nm)</td><td>Length (μm)</td><td>SSA (m2/g)</td><td>PC Sets</td><td>PC Names</td></tr><tr><td>F1</td><td>_</td><td>_</td><td>10–20</td><td>30–100</td><td>>165</td><td>M</td><td>M1</td></tr></table> | <table><tr><td>CNTs</td><td>Hydroxyl Content % (w/w)</td><td>Carboxyl Content % (w/w)</td><td>Diameter (nm)</td><td>Length (μm)</td><td>SSA (m2/g)</td><td>PC Sets</td><td>PC Names</td></tr><tr><td>F2</td><td>_</td><td>_</td><td>8–15</td><td>~50</td><td>>233</td><td>M</td><td>M2</td></tr><tr><td>F3</td><td>_</td><td>_</... |
21e9a99b219c6e866c53e7ae2d8e8145f34627e216bf6ec561dc5b95e6ffa946.png | complex | <table><tr><td rowspan="3"></td><td colspan="9">Median MET-min/week (IQR)</td></tr><tr><td colspan="2">Erectile dysfunction</td><td rowspan="2"><i>p</i> value</td><td colspan="2">Premature ejaculation</td><td rowspan="2"><i>p</i> value</td><td colspan="2">Libido</td><td rowspan="2"><i>p</i> value</td></tr><tr><td>Absen... | <table><tr><td rowspan="3"></td><td colspan="9">Median MET-min/week (IQR)</td></tr><tr><td colspan="2">Erectile dysfunction</td><td rowspan="2">p value</td><td colspan="2">Premature ejaculation</td><td rowspan="2">p value</td><td colspan="2">Libido</td><td rowspan="2">p value</td></tr><tr><td>Absent</td><td>Present</td... | <table><tr><td>South Asians</td><td>1853 (2772)</td><td>1538 (3025)</td><td>0.361</td><td>1737 (3699)</td><td>1809 (3304)</td><td>0.879</td><td>1746 (3063)</td><td>1280 (3722)</td><td>0.398</td></tr></table> |
c0be9cb44095a3c469a1d0a15d19de4bbaf0bd418806ba7dabeb637f725a7c91.png | simple | <table><tr><td>Subjects</td><td>Age (years)</td><td>Odor threshold (score/16)</td><td>Odor discrimination (score/16)</td><td>Multiple choice identification (score/16)</td><td>TDI composite score (score/48)</td><td>Retronasal testing (score/20)</td></tr><tr><td>EB1</td><td>21</td><td>7.3</td><td>15</td><td>10</td><td>32... | <table><tr><td>Subjects</td><td>Age (years)</td><td>Odor threshold (score/16)</td><td>Odor discrimination (score/16)</td><td>Multiple choice identification (score/16)</td></tr><tr><td>EB1</td><td>21</td><td>7.3</td><td>15</td><td>10</td></tr><tr><td>EB3</td><td>29</td><td>6.3</td><td>10</td><td>16</td></tr><tr><td>EB4<... | <table><tr><td>TDI composite score (score/48)</td><td>Retronasal testing (score/20)</td></tr><tr><td>32.3</td><td>19</td></tr><tr><td>32.3</td><td>16</td></tr><tr><td>35.0</td><td>17</td></tr><tr><td>43.8</td><td>18</td></tr><tr><td>38.0</td><td>17</td></tr><tr><td>37.0</td><td>17</td></tr><tr><td>42.8</td><td>18</td><... |
2e6e7d2429967eb49d0c4d4d40f71e3a1b2a42b7984172719129b925841ce0a7.png | complex | <table><tr><td rowspan="2">Sample</td><td colspan="6">Number of lethality (%)</td></tr><tr><td colspan="2"><i>Tribolium castaneum</i></td><td colspan="2"><i>Rhyzopertha dominica</i></td><td colspan="2"><i>Callosbruchus analis</i></td></tr><tr><td>Crude extract</td><td>0.33 ± 0.57</td><td>3.3 ± 5.7</td><td>0</... | <table><tr><td rowspan="2">Sample</td><td colspan="6">Number of lethality (%)</td></tr><tr><td colspan="2">Tribolium castaneum</td><td colspan="2">Rhyzopertha dominica</td><td colspan="2">Callosbruchus analis</td></tr><tr><td>Crude extract</td><td>0.33 ± 0.57</td><td>3.3 ± 5.7</td><td>0</td><td>0</td><td>0</td><td>0</t... | <table><tr><td>n-butanol</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0.66 ± 0.57</td><td>6.6 ± 5.7</td></tr><tr><td>Aqueous</td><td>0</td><td>0</td><td>1.33 ± 0.57</td><td>13.3 ± 5.7</td><td>0</td><td>0</td></tr><tr><td>Permethrin (standard)</td><td>10 ± 0</td><td>100</td><td>10 ± 0</td><td>100</td><td>10 ± 0.01</t... |
0260fff33957cd5e4cea168bd70114418f5ddb64af363a35a1ffa5cd6379242c.png | simple | <table><tr><td></td><td>Sarcoidosis<i>N</i> = 17</td><td>Control disease<i>N</i> = 11</td><td>Tuberculosis<i>N</i> = 8</td><td><i>P</i> Value</td></tr><tr><td>Age, mean ± SD (years)</td><td>53.12 ± 7.41</td><td>53.55 ± 12.75</td><td>45.13 ± 20.73</td><td>0.3013</td></tr><tr><td>Male/female ratio</td... | <table><tr><td></td><td>SarcoidosisN = 17</td><td>Control diseaseN = 11</td><td>TuberculosisN = 8</td></tr><tr><td>Age, mean ± SD (years)</td><td>53.12 ± 7.41</td><td>53.55 ± 12.75</td><td>45.13 ± 20.73</td></tr><tr><td>Male/female ratio</td><td>3/14</td><td>6/5</td><td>6/2</td></tr><tr><td>CXR stage: 0/I/II/III/IV num... | <table><tr><td>P Value</td></tr><tr><td>0.3013</td></tr><tr><td>N/A</td></tr><tr><td>N/A</td></tr><tr><td>N/A</td></tr><tr><td>0.1564</td></tr><tr><td>N/A</td></tr><tr><td>0.5996</td></tr><tr><td>N/A</td></tr><tr><td>0.1380</td></tr><tr><td>0.7526</td></tr><tr><td>0.1730</td></tr><tr><td>0.3607</td></tr><tr><td>0.0734<... |
45004dd263b0a6c8546d91dd99324c5516790b70746bd61c7bf90816ae929d3a.png | simple | <table><tr><td>Comet class</td><td>0</td><td>1</td><td>2</td><td>3</td><td>4</td><td>TCS</td></tr><tr><td>Exposed group</td><td>21.6 ± 13.4</td><td>32.5 ± 14.2</td><td>15.8 ± 11.9</td><td>11.3 ± 9.9</td><td>18.7 ± 9.4</td><td>173.2 ± 50.1*</td></tr><tr><td>Control group</td><td>67.7 ±... | <table><tr><td>Comet class</td><td>0</td><td>1</td><td>2</td><td>3</td><td>4</td><td>TCS</td></tr></table> | <table><tr><td>Exposed group</td><td>21.6 ± 13.4</td><td>32.5 ± 14.2</td><td>15.8 ± 11.9</td><td>11.3 ± 9.9</td><td>18.7 ± 9.4</td><td>173.2 ± 50.1*</td></tr><tr><td>Control group</td><td>67.7 ± 13.0</td><td>16.2 ± 8.0</td><td>7.1 ± 4.4</td><td>5.3 ± 4.1</td><td>3.7 ± 2.3</td><td>61.0 ± 25.0</td></tr></table> |
99f50d74bb134edb5fe9723d214d32dc2d5233b0171e3bd1575c44a08121ff1b.png | simple | <table><tr><td>Cost<sup>a</sup></td><td>Argentina</td><td>Brazil</td><td>Chile</td><td>Colombia</td><td>Ecuador</td><td>Mexico</td><td>Peru</td></tr><tr><td>< 1</td><td>Rivaroxavan</td><td>Rivaroxavan</td><td>Rivaroxavan</td><td>Rivaroxavan</td><td>–</td><td>Rivaroxavan</td><td>Rivaroxavan</td></tr><tr><td>1&#... | <table><tr><td>Costa</td><td>Argentina</td><td>Brazil</td><td>Chile</td></tr><tr><td>< 1</td><td>Rivaroxavan</td><td>Rivaroxavan</td><td>Rivaroxavan</td></tr><tr><td>1–4</td><td>Apixaban, Indacaterol, Linagliptin, Ticagrelor</td><td>Apixaban, Roflumilast, Ticagrelor</td><td>Apixaban, Indacaterol</td></tr><tr><td>5–9</t... | <table><tr><td>Colombia</td><td>Ecuador</td><td>Mexico</td><td>Peru</td></tr><tr><td>Rivaroxavan</td><td>–</td><td>Rivaroxavan</td><td>Rivaroxavan</td></tr><tr><td>Apixaban, Indacaterol</td><td>Indacaterol</td><td>–</td><td>–</td></tr><tr><td>–</td><td>–</td><td>Azilsartan, Linagliptin</td><td>–</td></tr><tr><td>–</td>... |
aa45822eae4371a9168ebbba063a7dcb62cd5b1e3c3ec28c80a2d77d5fb031b3.png | complex | <table><tr><td>Origin</td><td>Methods</td><td>Dysregulated miRNAs</td><td>Study Details</td></tr><tr><td colspan="4"><i>Aortic stenosis</i></td></tr><tr><td>Aortic valve leaflets [24]</td><td>Microarray qPCR</td><td>Downregulated: 26a, 30b, 195</td><td>9 patients with BAV (AS vs. aortic insufficiency requiring AVR)</td... | <table><tr><td>Origin</td><td>Methods</td><td>Dysregulated miRNAs</td></tr><tr><td colspan="3">Aortic stenosis</td></tr><tr><td>Aortic valve leaflets [24]</td><td>Microarray qPCR</td><td>Downregulated: 26a, 30b, 195</td></tr><tr><td>Aortic valve leaflets [26]</td><td>qPCR</td><td>Downregulated: 30b</td></tr><tr><td>Aor... | <table><tr><td>Study Details</td></tr><tr><td>Aortic stenosis</td></tr><tr><td>9 patients with BAV (AS vs. aortic insufficiency requiring AVR)</td></tr><tr><td>10 AS patients requiring AVR (calcific vs. adjacent tissue)</td></tr><tr><td>4 BAVs vs. healthy aortic valves</td></tr><tr><td>20 calcific AS valves vs. 6 contr... |
12dc63f046a63ee8c34334c08b8b7182d947bfd99503f2bfea365426324380cd.png | simple | <table><tr><td>Variable</td><td>Base case value</td><td>Distribution</td><td>Parameters</td><td>Source/Notes</td></tr><tr><td>Probability of sustained virological response (SVR) in control group</td><td>0.02%</td><td>Beta</td><td>Alpha = 1 Beta = 559</td><td>Koretz et al.[23]</td></tr><tr><td>Log risk ratio (SVR: inter... | <table><tr><td>Variable</td><td>Base case value</td></tr><tr><td>Probability of sustained virological response (SVR) in control group</td><td>0.02%</td></tr><tr><td>Log risk ratio (SVR: interferon versus no-intervention control)</td><td>2.9209</td></tr><tr><td>5-year probability of death in no-intervention control grou... | <table><tr><td>Distribution</td><td>Parameters</td><td>Source/Notes</td></tr><tr><td>Beta</td><td>Alpha = 1 Beta = 559</td><td>Koretz et al.[23]</td></tr><tr><td>Normal</td><td>Mean = 2.9209 Standard deviation = 1.0255</td><td>Koretz et al.[23] Note this yields a base case probability of SVR in the interferon group of ... |
5787aa8eff1d474851080ee9af6c0150ccd83b5ed24a23da92091062d1e946c8.png | complex | <table><tr><td rowspan="2"></td><td colspan="3">CI session</td><td colspan="3">MDMA + CI session</td><td colspan="3"><i>F</i> value</td></tr><tr><td>T1</td><td>T2</td><td>T3</td><td>T1</td><td>T2</td><td>T3</td><td>Session</td><td>Time</td><td>Session × Time</td></tr><tr><td>TPAS—active</td><td>16.10 (6.04)<... | <table><tr><td></td><td colspan="3"></td><td colspan="3">MDMA + CI s</td><td colspan="3"></td></tr></table> | <table><tr><td rowspan="2"></td><td colspan="3">CI session</td><td colspan="3">ession</td><td colspan="3">F value</td></tr><tr><td>T1</td><td>T2</td><td>T3</td><td>T1</td><td>T2</td><td>T3</td><td>Session</td><td>Time</td><td>Session × Time</td></tr><tr><td>TPAS—active</td><td>16.10 (6.04)</td><td>15.40 (5.85)</td><td>... |
728c3cef161dd94d5a3c6980570a7d68ba8e832cd778c11708141e1dc79ad778.png | complex | <table><tr><td>Tx-type; Cause of Death</td><td>< 12 months</td><td>> 12 months</td><td><i>p</i>-value</td></tr><tr><td>Total: 278</td><td></td><td></td><td></td></tr><tr><td colspan="4">SLTx (<i>n</i> = 97)</td></tr><tr><td> Total number of deaths</td><td>17</td><td>51</td><td>0.158</td></tr><tr><td> Death from O... | <table><tr><td>Tx-type; Cause of Death</td><td>< 12 months</td><td>> 12 months</td><td>p-value</td></tr><tr><td>Total: 278</td><td></td><td></td><td></td></tr><tr><td colspan="4">SLTx (n = 97)</td></tr><tr><td>Total number of deaths</td><td>17</td><td>51</td><td>0.158</td></tr><tr><td>Death from Organ Rejection</td><td... | <table><tr><td>Death from Infection</td><td>0 (0%)</td><td>0 (0%)</td><td></td></tr><tr><td>Death from Malignancy</td><td>0 (0%)</td><td>0 (0%)</td><td></td></tr><tr><td>Death from Other Causes</td><td>1 (100%)</td><td>3 (75%)</td><td></td></tr></table> |
8f633e6dab81206083faaa3c3a704cbb871b7f5eb918d651332b94ce10bf08dc.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="2">Bivariate linear regression</td><td colspan="2">Multivariate linear regression</td></tr><tr><td>Coefficient (95 % CI)</td><td><i>P</i>-value</td><td>Coefficient (95 % CI)</td><td><i>P</i>-value</td></tr><tr><td>Male gender</td><td>5.707 (2.887, 8.526)</td><td><... | <table><tr><td rowspan="2">Variable</td><td colspan="2">Bivariate linear regression</td><td colspan="2">Multivariate linear regression</td></tr><tr><td>Coefficient (95 % CI)</td><td>P-value</td><td>Coefficient (95 % CI)</td><td>P-value</td></tr><tr><td>Male gender</td><td>5.707 (2.887, 8.526)</td><td><0.001</td><td>5.4... | <table><tr><td rowspan="2">Variable</td><td colspan="2">Bivariate linear regression</td><td colspan="2">Multivariate linear regression</td></tr><tr><td>Coefficient (95 % CI)</td><td>P-value</td><td>Coefficient (95 % CI)</td><td>P-value</td></tr><tr><td>Felt number of skills lab assistants was adequate</td><td>2.835 (−0... |
04ee76968c76d4f5db34842a59b5c8b72728dcf16b7edbe54b7af872935d8a7c.png | complex | <table><tr><td> </td><td>Total (<i>n</i> = 370)</td><td>Qi deficiency of spleen and kidney (<i>n</i> = 273)</td><td>Deficiency of both qi and yin (<i>n</i> = 66)</td><td>Other types (<i>n</i> = 31)</td><td><i>P</i> value</td></tr><tr><td>Age (years)</td><td>32 (27–42)</td><td>33 (27–42)</td><td>29 (25–... | <table><tr><td></td><td>Total (n = 370)</td><td>Qi deficiency of spleen and kidney (n = 273)</td><td>Deficiency of both qi and yin (n = 66)</td><td>Other types (n = 31)</td><td>P value</td></tr><tr><td>Age (years)</td><td>32 (27–42)</td><td>33 (27–42)</td><td>29 (25–36)</td><td>37 (28–46)</td><td>0.025a</td></tr><tr><t... | <table><tr><td></td><td>Total (n = 370)</td><td>Qi deficiency of spleen and kidney (n = 273)</td><td>Deficiency of both qi and yin (n = 66)</td><td>Other types (n = 31)</td><td>P value</td></tr><tr><td>BC (/μL)</td><td>(15–136)</td><td>)</td><td>(30–110)</td><td>)</td><td>5d</td></tr><tr><td>Hemoglobin (g/L)</td><td>12... |
6725e762f54bdd3222790dc6795adfaf3a1ff9c78792d1ea3a867cdc4720208a.png | complex | <table><tr><td>Growth year</td><td>Thickness/μm</td><td>Sheet name</td><td>Brix degree/%</td><td>Acid value/%</td><td>Peel color/a value</td></tr><tr><td rowspan="3">2004</td><td rowspan="3">30</td><td>unmulched</td><td>9.0 ± 0.3</td><td>0.68 ± 0.05</td><td>21.7 ± 1.0</td></tr><tr><td>MS-3,7,0</td><... | <table><tr><td>Growth year</td><td>Thickness/μm</td><td>Sheet name</td><td>Brix degree/%</td><td>Acid value/%</td><td>Peel color/a value</td></tr><tr><td rowspan="2">2004</td><td rowspan="2">30</td><td>unmulched</td><td>9.0 ± 0.3</td><td>0.68 ± 0.05</td><td>21.7 ± 1.0</td></tr><tr><td>MS-3,7,0</td><td>10.3 ± 0.2</td><t... | <table><tr><td>Growth year</td><td>Thickness/μm</td><td>Sheet name</td><td>Brix degree/%</td><td>Acid value/%</td><td>Peel color/a value</td></tr><tr><td>2004</td><td>30</td><td>MS-3,6,1</td><td>10.9 ± 0.6</td><td>0.74 ± 0.11</td><td>25.1 ± 1.2</td></tr><tr><td rowspan="3">2005</td><td rowspan="3">90</td><td>unmulched<... |
e281ae665d1292ae93651df0d64ad027e0b0bbf6733e7accf0fcc72f09ebe162.png | complex | <table><tr><td rowspan="2">Post Hoc Test (1 mL)</td><td rowspan="2">Age group (<i>i</i>)</td><td rowspan="2">Age Group (<i>j</i>)</td><td rowspan="2">Mean Difference (μ<i><sub>i</sub></i> − μ<i><sub>j</sub></i>)</td><td colspan="2">95% Confidence Interval</td></tr><tr><td>Lower</td><td>Upper</td></tr><t... | <table><tr><td rowspan="2">Post Hoc Test (1 mL)</td><td rowspan="2">Age group (i)</td><td rowspan="2">Age Group (j)</td><td rowspan="2">Mean Difference (μi − μj)</td><td colspan="2">95% Confidence Interval</td></tr><tr><td>Lower</td><td>Upper</td></tr><tr><td rowspan="2">Scheffé’s *</td><td>51–60</td><td>21–30</td><td... | <table><tr><td rowspan="2">Post Hoc Test (1 mL)</td><td rowspan="2">Age group (i)</td><td rowspan="2">Age Group (j)</td><td rowspan="2">Mean Difference (μi − μj)</td><td colspan="2">95% Confidence Interval</td></tr><tr><td>Lower</td><td>Upper</td></tr><tr><td>Scheffé’s *</td><td>21–30</td><td>31–50</td><td>0.183</td><... |
0560b68fc3e907f3b0ab1e438c45edb6ba05434382f623932635506ea50f3eeb.png | complex | <table><tr><td>Variable</td><td>ALSPAC n (%)(N=6768)</td><td>Pelotas n (%)(N=3508)</td><td>χ<sup>2</sup></td></tr><tr><td colspan="4">Exposures</td></tr><tr><td> Low birth weight</td><td>238 (3.5)</td><td>274 (7.8)</td><td>89.99**</td></tr><tr><td> SGA</td><td>512 (7.6)</td><td>496 (14.2)</td><td>113.19**</td></tr... | <table><tr><td>Variable</td><td>ALSPAC n (%)(N=6768)</td><td>Pelotas n (%)(N=3508)</td><td>χ2</td></tr><tr><td colspan="4">Exposures</td></tr></table> | <table><tr><td>Variable</td><td>ALSPAC n (%)(N=6768)</td><td>Pelotas n (%)(N=3508)</td><td>χ2</td></tr><tr><td>Low birth weight</td><td>238 (3.5)</td><td>274 (7.8)</td><td>89.99**</td></tr><tr><td>SGA</td><td>512 (7.6)</td><td>496 (14.2)</td><td>113.19**</td></tr><tr><td>Small HC</td><td>264 (4.8)</td><td>470 (13.4)</t... |
7d957e598a95d7010dfc705d5b42f4fdb0c7f9f9c0ac0158b39826db54a2e372.png | simple | <table><tr><td></td><td>Histopathological score</td><td></td><td></td></tr><tr><td></td><td>Day 7</td><td>Day 21</td><td>Day 35</td></tr><tr><td>Gb</td><td>2(1-2)</td><td>6(5-7)</td><td>8,5(7-10)</td></tr><tr><td>C</td><td>2(1-2)</td><td>5(4-6)</td><td>6(6-7)</td></tr><tr><td>p</td><td>0,535</td><td>0,009*</td><td>0,00... | <table><tr><td></td><td>Histopathological score</td><td></td><td></td></tr><tr><td></td><td>Day 7</td><td>Day 21</td><td>Day 35</td></tr></table> | <table><tr><td>Gb</td><td>2(1-2)</td><td>6(5-7)</td><td>8,5(7-10)</td></tr><tr><td>C</td><td>2(1-2)</td><td>5(4-6)</td><td>6(6-7)</td></tr><tr><td>p</td><td>0,535</td><td>0,009*</td><td>0,001*</td></tr></table> |
b4f209366490f439e916f653e885ac45dc201668c39fcf71553f5d54b0837dab.png | complex | <table><tr><td rowspan="2">Systemic organ class and preferred term<sup>a</sup></td><td colspan="2">Total (<i>N</i> = 209)</td></tr><tr><td>Number of Subjects (%)</td><td>Number of Adverse Events</td></tr><tr><td colspan="3">Resistance mechanism disorders</td></tr><tr><td> Infection susceptibility increased</td><td>1 (0... | <table><tr><td rowspan="2">Systemic organ class and preferred terma</td><td>Total (N = 209)</td></tr><tr><td>Number of Subjects (%)</td></tr><tr><td colspan="2">Resistance mechanism disorders</td></tr><tr><td>Infection susceptibility increased</td><td>1 (0.48)</td></tr><tr><td>Polyomavirus infection</td><td>1 (0.48)</t... | <table><tr><td>Total (N = 209)</td></tr><tr><td>Number of Adverse Events</td></tr><tr><td>Resistance mechanism disorders</td></tr><tr><td>1</td></tr><tr><td>1</td></tr><tr><td>Gastro-intestinal system disorders</td></tr><tr><td>5</td></tr><tr><td>3</td></tr><tr><td>1</td></tr><tr><td>2</td></tr><tr><td>1</td></tr><tr><... |
633adc2003522ca566a40b37a5f22a2f81297b6bee44f2f1f9dd5124677dbab9.png | complex | <table><tr><td rowspan="2">Variable</td><td rowspan="2">Category</td><td>IIR</td><td>Non- IIR</td><td>Total</td></tr><tr><td><i>n</i> (%)</td><td><i>n</i> (%)</td><td><i>n</i> (%)</td></tr><tr><td>Age</td><td>≥ 35 years</td><td>31 (38.3)</td><td>31 (38.3)</td><td>62 (38.3)</td></tr><tr><td>Marital status</td><td>... | <table><tr><td rowspan="2">Variable</td><td rowspan="2">Category</td><td>IIR</td><td>Non- IIR</td><td>Total</td></tr><tr><td>n (%)</td><td>n (%)</td><td>n (%)</td></tr><tr><td>Age</td><td>≥ 35 years</td><td>31 (38.3)</td><td>31 (38.3)</td><td>62 (38.3)</td></tr><tr><td>Marital status</td><td>Married</td><td>74 (91.4)</... | <table><tr><td rowspan="2">Variable</td><td rowspan="2">Category</td><td>IIR</td><td>Non- IIR</td><td>Total</td></tr><tr><td>n (%)</td><td>n (%)</td><td>n (%)</td></tr><tr><td>Prior work experience</td><td>Yes</td><td>14 (17.3)</td><td>09 (11.1)</td><td>23 (14.2)</td></tr><tr><td rowspan="6">Primary reason of join Mita... |
a5e345fd37dd238b8f174b92561039c6bc603505bad4ec2d70a0c7093ef71f96.png | simple | <table><tr><td>ID</td><td>Study</td><td>IQC</td><td>EQC</td><td>CQCg</td><td>CQCp</td><td>AQCg</td><td>AQCp</td><td>SMR</td><td>Quality</td></tr><tr><td>1</td><td>GSE43264</td><td>4.02</td><td>4</td><td>2.51</td><td>3.32</td><td>2.63</td><td>4.54</td><td>2.67</td><td>high</td></tr><tr><td>2</td><td>GSE48301_eSF</td><td... | <table><tr><td>ID</td><td>Study</td><td>IQC</td><td>EQC</td><td>CQCg</td><td>CQCp</td><td>AQCg</td><td>AQCp</td><td>SMR</td><td>Quality</td></tr><tr><td>1</td><td>GSE43264</td><td>4.02</td><td>4</td><td>2.51</td><td>3.32</td><td>2.63</td><td>4.54</td><td>2.67</td><td>high</td></tr><tr><td>2</td><td>GSE48301_eSF</td><td... | <table><tr><td>9</td><td>GSE5090</td><td>0.98*</td><td>1.68*</td><td>0.51*</td><td>0.77*</td><td>1.86*</td><td>0.05*</td><td>8.33</td><td>low</td></tr><tr><td>10</td><td>GSE5850</td><td>0*</td><td>2.32*</td><td>0.05*</td><td>3.07</td><td>0.07*</td><td>0.41*</td><td>8.5</td><td>low</td></tr><tr><td>11</td><td>GSE10946_l... |
b7d63750bb0e9784ddf9336a9fcd918a62ad453fd97d29edc0848c1db7d4a969.png | complex | <table><tr><td rowspan="2">Variables</td><td colspan="2">Univariable</td><td colspan="2">Multivariable</td></tr><tr><td>HR (95% CI)</td><td><i>P</i></td><td>HR (95% CI)</td><td><i>P</i></td></tr><tr><td>Age (≤54/>54)</td><td>1.698 (0.860–3.354)</td><td>0.127</td><td></td><td></td></tr><tr><td>Gender (F/M... | <table><tr><td rowspan="2">Variables</td><td colspan="2">Univariable</td><td colspan="2">Multivariable</td></tr><tr><td>HR (95% CI)</td><td>P</td><td>HR (95% CI)</td><td>P</td></tr><tr><td>Age (≤54/>54)</td><td>1.698 (0.860–3.354)</td><td>0.127</td><td></td><td></td></tr><tr><td>Gender (F/M)</td><td>0.551 (0.282–1.075)... | <table><tr><td>Tumor location (pyloric/nonpyloric antrum)</td><td>1.130 (0.580–2.204)</td><td>0.719</td><td></td><td></td></tr><tr><td>HER-2 (positive/negative)</td><td>1.818 (0.698–4.736)</td><td>0.221</td><td></td><td></td></tr><tr><td>RDW (≤13.4%/>13.4%)</td><td>3.497 (1.713–7.140)</td><td>0.001</td><td></td><td></t... |
277d7aac02dc1b79c8c35cf73cbd14dad12b4efbab0cb9393316c4dee0735d4e.png | complex | <table><tr><td></td><td>Parent, <i>N</i> = 100/217</td><td>Child, <i>N</i> = 63/130</td></tr><tr><td>Missing values (1st–3rd quartiles)</td><td>No missing values</td><td>No missing values</td></tr><tr><td>Response pattern</td><td>PF and HRQoL positively skewed</td><td>PF and HRQoL positively skewed</td></tr><tr><... | <table><tr><td></td><td>Parent, N = 100/217</td><td>Child, N = 63/130</td></tr><tr><td>Missing values (1st–3rd quartiles)</td><td>No missing values</td><td>No missing values</td></tr><tr><td>Response pattern</td><td>PF and HRQoL positively skewed</td><td>PF and HRQoL positively skewed</td></tr><tr><td colspan="3">Floor... | <table><tr><td></td><td>Parent, N = 100/217</td><td>Child, N = 63/130</td></tr><tr><td>eing VAS</td><td>.0%</td><td></td></tr><tr><td>Items with equivalent item-scale correlation</td><td>87% for PF, 90% for HRQoL</td><td>73% for PF, 90% for HRQoL</td></tr><tr><td>Items with items-scale correlation ≥ 0.4</td><td>87% for... |
4c2da8a8a8c57b298f97601aea9fe745c20be56afb969de1c93a48c046ac98e1.png | complex | <table><tr><td></td><td colspan="3"><i>n</i> (%) of sites</td></tr><tr><td></td><td>Dacron (<i>N</i> = 38<sup>b</sup>)</td><td>PTFE (<i>N</i> = 19<sup>b</sup>)</td><td>Any material (<i>N</i> = 57<sup>b</sup>)</td></tr><tr><td colspan="4">Bleeding<sup>a</sup> at 0 min</td></tr><tr><td>“No bleeding”</td><td>3... | <table><tr><td></td><td colspan="3">n (%) of sites</td></tr><tr><td></td><td>Dacron (N = 38b)</td><td>PTFE (N = 19b)</td><td>Any material (N = 57b)</td></tr><tr><td colspan="4">Bleedinga at 0 min</td></tr><tr><td>“No bleeding”</td><td>34 (89)</td><td>19 (100)</td><td>53 (93)</td></tr><tr><td>“Oozing”</td><td>4 (11)</td... | <table><tr><td>“Oozing”</td><td>1 (3)</td><td>0 (0)</td><td>1 (2)</td></tr><tr><td>“No bleeding” or “oozing”</td><td>38 (100)</td><td>19 (100)</td><td>57 (100)</td></tr></table> |
13dfe521296df7fa05b3256b8b83bbd296979b235b7721ed57f5d1ba1021f733.png | complex | <table><tr><td></td><td colspan="3">Fraction in state (f)</td><td>z<sub>2t</sub></td><td colspan="4">Rates of transfer (Eqs. (20)–(21))</td></tr><tr><td>Time</td><td>U</td><td>J</td><td>A</td><td></td><td><i>m</i><sub>UJ</sub></td><td><i>m</i><sub>JU</sub></td><td><i>m</i><sub>JA</sub></td><td><i>m</i><sub>AJ</su... | <table><tr><td></td><td colspan="3">Fraction in state (f)</td><td>z2t</td><td colspan="4">Rates of transfer (Eqs. (20)–(21))</td></tr><tr><td>Time</td><td>U</td><td>J</td><td>A</td><td></td><td>mUJ</td><td>mJU</td><td>mJA</td><td>mAJ</td></tr><tr><td colspan="9">A. Interval by interval calculations (Eq. (1))</td></tr><... | <table><tr><td>5</td><td>.74184</td><td>.14837</td><td>.10979</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="8">C. Time 5 values calculated directly from time 0 populations and z values (Eq. (2))</td><td></td></tr><tr><td>5</td><td>.77844</td><td>.13275</td><td>.08881</td><td></td><td></td><td><... |
22e89c02e27d163cde0028fa562cb4f415e9fb6b68dd99b7ab1221cdb5606fd8.png | complex | <table><tr><td>Variable</td><td>N</td><td>%</td></tr><tr><td colspan="3"><i>Child’s gender</i></td></tr><tr><td>Male</td><td>232</td><td>48.54</td></tr><tr><td>Female</td><td>246</td><td>52.46</td></tr><tr><td colspan="3"><i>Child’s age (months)</i></td></tr><tr><td>12–35</td><td>186</td><td>38.91</td... | <table><tr><td>Variable</td><td>N</td><td>%</td></tr><tr><td colspan="3">Child’s gender</td></tr><tr><td>Male</td><td>232</td><td>48.54</td></tr><tr><td>Female</td><td>246</td><td>52.46</td></tr><tr><td colspan="3">Child’s age (months)</td></tr><tr><td>12–35</td><td>186</td><td>38.91</td></tr><tr><td>36–59</td><td>292<... | <table><tr><td>Variable</td><td>N</td><td>%</td></tr><tr><td colspan="3">Father’s level of education</td></tr><tr><td>≥8 years</td><td>247</td><td>55.38</td></tr><tr><td><8 years</td><td>199</td><td>44.62</td></tr><tr><td colspan="3">Does the child brush his/her teeth?</td></tr><tr><td>Yes</td><td>434</td><td>90.99</td... |
964e522bced69f89d6f6c8e189e6e9b58b2cb17039b55c178bfd7ea803ba7087.png | complex | <table><tr><td colspan="5">Box D. Content validity (including face validity)</td></tr><tr><td colspan="2"><i>General requirements</i></td><td>yes</td><td>no</td><td>?</td></tr><tr><td>1</td><td>Was assessed if all items refer to relevant aspects of the construct to be measured?</td><td>□</td><td>□</td><td>&... | <table><tr><td colspan="5">Box D. Content validity (including face validity)</td></tr><tr><td colspan="2">General requirements</td><td>yes</td><td>no</td><td>?</td></tr><tr><td>1</td><td>Was assessed if all items refer to relevant aspects of the construct to be measured?</td><td>□</td><td>□</td><td>□</td></tr><tr><td>2... | <table><tr><td>3</td><td>nd/or (3) predictive (predict future values)</td><td></td><td></td><td></td></tr><tr><td>4</td><td>Was assessed if all items together comprehensively reflect the construct to be measured in terms of (1) content coverage and description of domains, and (2) the theoretical foundation?</td><td>□</... |
4105867cb645b53ed2e2c5e2d0b3a5ed8acdc2c0b7c54a220037ffac017649ed.png | simple | <table><tr><td></td><td>Single cellular RNA sample</td><td>Pooled RNA sample</td><td>Pooled DNA sample</td></tr><tr><td>TNF-α</td><td>95</td><td>95</td><td>100</td></tr><tr><td>β2-MG</td><td>90</td><td>90</td><td>100</td></tr><tr><td>MIF</td><td>88</td><td>88</td><td>100</td></tr><tr><td>UBC</td><td>81</td><t... | <table><tr><td></td><td>Single cellular RNA sample</td><td>Pooled RNA sample</td><td>Pooled DNA sample</td></tr><tr><td>TNF-α</td><td>95</td><td>95</td><td>100</td></tr><tr><td>β2-MG</td><td>90</td><td>90</td><td>100</td></tr></table> | <table><tr><td>MIF</td><td>88</td><td>88</td><td>100</td></tr><tr><td>UBC</td><td>81</td><td>80</td><td>100</td></tr></table> |
84c8014a7543ba13b5894da15608468b8b4c5731816a896bf53098368adb6334.png | complex | <table><tr><td rowspan="2"></td><td>Total <i>n</i> = 1645</td><td>non-JIA <i>n</i> = 1316</td><td>JIA <i>n</i> = 329</td><td></td></tr><tr><td><i>n</i> %</td><td><i>n</i> %</td><td><i>n</i> %</td><td><i>P</i>-value</td></tr><tr><td>Age (year), mean ± SD<sup>a</sup></td><td>11.3 ± 3.47</td><td>11.3 ± 3.47... | <table><tr><td rowspan="2"></td><td>Total n = 1645</td><td>non-JIA n = 1316</td><td>JIA n = 329</td><td></td></tr><tr><td>n %</td><td>n %</td><td>n %</td><td>P-value</td></tr><tr><td>Age (year), mean ± SDa</td><td>11.3 ± 3.47</td><td>11.3 ± 3.47</td><td>11.3 ± 3.47</td><td>0.95</td></tr><tr><td>Stratified age</td><td><... | <table><tr><td rowspan="2"></td><td>Total n = 1645</td><td>non-JIA n = 1316</td><td>JIA n = 329</td><td></td></tr><tr><td>n %</td><td>n %</td><td>n %</td><td>P-value</td></tr><tr><td>Urbanizationb</td><td></td><td></td><td></td><td>0.99</td></tr><tr><td>1 (highest)</td><td>495 (30.1)</td><td>396 (30.1)</td><td>99 (30.1... |
8563bda3f8b8b277dbe27c0b23a2a4e335b1fda2e9532282996d1ec70add75cb.png | complex | <table><tr><td rowspan="2"></td><td colspan="3">cn/cn</td><td colspan="3">cn/+</td></tr><tr><td>Growth plates studied</td><td># Histologic sections</td><td>Range of # of sections per growth plate</td><td>Growth plates studied</td><td># Histologic sections</td><td>Range of # of sections per growth plate</td></tr><tr><td... | <table><tr><td rowspan="2"></td><td colspan="3">cn/cn</td><td>cn/+</td></tr><tr><td>Growth plates studied</td><td># Histologic sections</td><td>Range of # of sections per growth plate</td><td>Growth plates studied</td></tr><tr><td>Humerus</td><td>12</td><td>46</td><td>(1–9)</td><td>8</td></tr><tr><td>Femur</td><td>7</t... | <table><tr><td colspan="2">cn/+</td></tr><tr><td># Histologic sections</td><td>Range of # of sections per growth plate</td></tr><tr><td>23</td><td>(2–5)</td></tr><tr><td>31</td><td>(2–11)</td></tr><tr><td>30</td><td>(2–6)</td></tr><tr><td>87</td><td></td></tr></table> |
ad22a0feeee4c72b94078e88f31aec3a1861aafda486b24a981d629fa31442c8.png | complex | <table><tr><td colspan="2"></td><td>Homicides (per 100,000)</td><td>DALY (thousands)</td></tr><tr><td colspan="2">World</td><td>7.9</td><td>21,701,428</td></tr><tr><td colspan="2">High income countries</td><td>2.7</td><td>886,297</td></tr><tr><td rowspan="6">Low–middle income countries</td><td>Africa</td><td>20.1... | <table><tr><td colspan="2"></td><td>Homicides (per 100,000)</td><td>DALY (thousands)</td></tr><tr><td colspan="2">World</td><td>7.9</td><td>21,701,428</td></tr><tr><td colspan="2">High income countries</td><td>2.7</td><td>886,297</td></tr><tr><td rowspan="6">Low–middle income countries</td><td>Africa</td><td>20.1</td><... | <table><tr><td colspan="2"></td><td>Homicides (per 100,000)</td><td>DALY (thousands)</td></tr><tr><td colspan="2">India (102)</td><td>4.4</td><td>1866</td></tr><tr><td colspan="2">Pakistan (108)</td><td>3.4</td><td>174</td></tr><tr><td colspan="2">Turkey (113)</td><td>2.8</td><td>67</td></tr><tr><td colspan="2">China (... |
73cc8244051bf2aa3d890c9e1f711fb82c5e92887d897b597c27cfa20cfd51f3.png | complex | <table><tr><td rowspan="2">Gene</td><td colspan="2">Fraction of <i>est2∆ rad51∆ xxx∆</i> that are able to form survivors</td><td rowspan="2">Reference</td></tr><tr><td>in BY4741 background<i><sup>a</sup></i></td><td>in W303 background</td></tr><tr><td><i>CCR4</i><i><sup>b</sup></i></td><td></td><td>0/... | <table><tr><td rowspan="2">Gene</td><td colspan="2">Fraction of est2∆ rad51∆ xxx∆ that are able to form survivors</td><td rowspan="2">Reference</td></tr><tr><td>in BY4741 backgrounda</td><td>in W303 background</td></tr><tr><td>CCR4b</td><td></td><td>0/10 (0%)</td><td></td></tr><tr><td>CDC55</td><td>0/12 (0%)</td><td>2/... | <table><tr><td rowspan="2">Gene</td><td colspan="2">Fraction of est2∆ rad51∆ xxx∆ that are able to form survivors</td><td rowspan="2">Reference</td></tr><tr><td>in BY4741 backgrounda</td><td>in W303 background</td></tr><tr><td>YLR358C</td><td>1/5 (20%)</td><td>4/9 (44%)</td><td></td></tr></table> |
7579a10b0761bd239950113d71845deedda1a85dd9e8f87f631417670d05f90f.png | complex | <table><tr><td></td><td colspan="7">Parity</td></tr><tr><td>Measurements</td><td>0</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6 or later</td></tr><tr><td>Number of serviced records</td><td>93,604</td><td>78,243</td><td>70,596</td><td>62,258</td><td>53,371</td><td>43,634</td><td>52,352</td></tr><tr><td>Nu... | <table><tr><td></td><td colspan="7">Parity</td></tr><tr><td>Measurements</td><td>0</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6 or later</td></tr><tr><td>Number of serviced records</td><td>93,604</td><td>78,243</td><td>70,596</td><td>62,258</td><td>53,371</td><td>43,634</td><td>52,352</td></tr><tr><td>Nu... | <table><tr><td>Number of removed records after the second returnb</td><td>394</td><td>232</td><td>168</td><td>136</td><td>90</td><td>68</td><td>64</td></tr><tr><td>Number of SRB femalesc</td><td>532</td><td>235</td><td>145</td><td>104</td><td>70</td><td>34</td><td>38</td></tr><tr><td>SRB risk for first-served females, ... |
4201751865a366a73f50c1598b6c856f75d34b3770ceb1116299faaed94945de.png | simple | <table><tr><td>Kidney cancer dataset</td><td>CANOVA</td><td>Kendall</td><td>Pearson</td><td>Spearman</td><td>Hoeffding</td><td>Distance</td><td>MIC</td></tr><tr><td>Significant gene number</td><td>5901</td><td>11569</td><td>8239</td><td>11629</td><td>4953</td><td>10946</td><td>8081</td></tr><tr><td>Computing time (seco... | <table><tr><td>Kidney cancer dataset</td><td>CANOVA</td><td>Kendall</td><td>Pearson</td><td>Spearman</td><td>Hoeffding</td><td>Distance</td><td>MIC</td></tr><tr><td>Significant gene number</td><td>5901</td><td>11569</td><td>8239</td><td>11629</td><td>4953</td><td>10946</td><td>8081</td></tr></table> | <table><tr><td>Computing time (seconds)</td><td>24</td><td>65</td><td>32</td><td>32</td><td>44</td><td>~106</td><td>114</td></tr></table> |
fe90ee019ad0e3f5e6ea67eb798a19b18b3beca6a467f525016c89ea031c1bbe.png | simple | <table><tr><td>Article</td><td>Number (M/F)<sup>1</sup></td><td>C/R/R-S<sup>2</sup></td><td>Age Mean ± SD<sup>3</sup>/Median (range)</td><td>ST<sup>4</sup></td><td>Cut-off</td><td>Rate(+)<sup>5</sup></td><td>Follow up Mean ± SD/Median (range)</td><td>OM<sup>6</sup></td><td>Surgery</td><td>MA<sup>7</sup></td><... | <table><tr><td>Article</td><td>Number (M/F)1</td><td>C/R/R-S2</td><td>Age Mean ± SD3/Median (range)</td><td>ST4</td><td>Cut-off</td><td>Rate(+)5</td><td>Follow up Mean ± SD/Median (range)</td><td>OM6</td><td>Surgery</td><td>MA7</td></tr><tr><td>Sotelo 2014 [24]</td><td>472(254/218)</td><td>425/47/0</td><td>Median:66(31... | <table><tr><td>Article</td><td>Number (M/F)1</td><td>C/R/R-S2</td><td>Age Mean ± SD3/Median (range)</td><td>ST4</td><td>Cut-off</td><td>Rate(+)5</td><td>Follow up Mean ± SD/Median (range)</td><td>OM6</td><td>Surgery</td><td>MA7</td></tr><tr><td></td><td>9(NR)</td><td>R</td><td>an: 64 (22–92)</td><td>aseline</td><td>3/7... |
9cea7c1dcc75bee28acca0f18898512416b6c9898e8435191b7fb6a1b7f39664.png | simple | <table><tr><td>Biomolecule</td><td>Molecular weight (kDa)</td><td>Isoelectric point</td><td>Charge</td><td>Hydrodynamic radius (Å)</td><td>Amount (μg)</td></tr><tr><td>AcSDKP peptide</td><td>0.4</td><td>5.5</td><td>Negative</td><td>7<sup>a</sup></td><td>1000</td></tr><tr><td>Insulin</td><td>5.73</td><td>5.3<... | <table><tr><td>Biomolecule</td><td>Molecular weight (kDa)</td><td>Isoelectric point</td><td>Charge</td><td>Hydrodynamic radius (Å)</td><td>Amount (μg)</td></tr><tr><td>AcSDKP peptide</td><td>0.4</td><td>5.5</td><td>Negative</td><td>7a</td><td>1000</td></tr><tr><td>Insulin</td><td>5.73</td><td>5.3</td><td>Negative</td>... | <table><tr><td>Lysozyme</td><td>14.3</td><td>11.35</td><td>Positive</td><td>19.1</td><td>1200 (transwell) 350 (release)</td></tr><tr><td>VEGF</td><td>45.5</td><td>9.22</td><td>Positive</td><td>30.2</td><td>7.5</td></tr><tr><td>BSA</td><td>66.4</td><td>4.7</td><td>Negative</td><td>36.3</td><td>1200</td></tr></table> |
05df35fd3cb6e167b0b2597e7edb7ebccd0c08aae4ef304d3bf20e52bd1a91dc.png | simple | <table><tr><td>Delivery system</td><td>Diameter (mm)</td><td>Headspace (ml)</td><td>Milk-to-air interface (cm<sup>2</sup>)</td></tr><tr><td>Gerber (G)</td><td>52</td><td>176</td><td>21.23</td></tr><tr><td>Ventaire (V)</td><td>54</td><td>183</td><td>22.89</td></tr><tr><td>Dr. Brown's (DB)</td><td>50</td><td>66*</td><td>... | <table><tr><td>Delivery system</td></tr><tr><td>Gerber (G)</td></tr><tr><td>Ventaire (V)</td></tr><tr><td>Dr. Brown's (DB)</td></tr><tr><td>Elan (EL)</td></tr><tr><td>BornFree (BF)</td></tr><tr><td>Playtex Drop-Ins (PD)</td></tr><tr><td>Avent Natural (AN)</td></tr><tr><td>Control</td></tr></table> | <table><tr><td>Diameter (mm)</td><td>Headspace (ml)</td><td>Milk-to-air interface (cm2)</td></tr><tr><td>52</td><td>176</td><td>21.23</td></tr><tr><td>54</td><td>183</td><td>22.89</td></tr><tr><td>50</td><td>66*</td><td>19.63</td></tr><tr><td>67</td><td>180</td><td>35.24*</td></tr><tr><td>65</td><td>127*</td><td>33.17*... |
688fcf8fff88d85403b3a87cad259fb7bd8ef65414b7f5e0ccc8af021f60a8db.png | complex | <table><tr><td colspan="4">Medium scale construction sites</td></tr><tr><td>Site</td><td>Total (max. = 120)</td><td>Mean</td><td>Correlation coefficient</td></tr><tr><td>1</td><td>58</td><td>4.83</td><td>0.56</td></tr><tr><td>2</td><td>48</td><td>4.00</td><td>−0.22</td></tr><tr><td>3</td><td>50</td><td>4.17</td><... | <table><tr><td colspan="4">Medium scale construction sites</td></tr><tr><td>Site</td><td>Total (max. = 120)</td><td>Mean</td><td>Correlation coefficient</td></tr><tr><td>1</td><td>58</td><td>4.83</td><td>0.56</td></tr><tr><td>2</td><td>48</td><td>4.00</td><td>−0.22</td></tr><tr><td>3</td><td>50</td><td>4.17</td><td>−0.... | <table><tr><td colspan="4">Medium scale construction sites</td></tr><tr><td>Site</td><td>Total (max. = 120)</td><td>Mean</td><td>Correlation coefficient</td></tr><tr><td>8</td><td>41</td><td>3.42</td><td>0.69</td></tr><tr><td>9</td><td>43</td><td>3.58</td><td>−0.09</td></tr><tr><td>10</td><td>51</td><td>4.25</td><td>0.... |
17f0e45152d67e9e521daa569b7e0dc79d2d9c24142a23c2e5b73d30f665b1fe.png | simple | <table><tr><td>Dataset</td><td>Nematode hits </td><td>Trematode hits </td><td>Cestode hits </td></tr><tr><td><i>C. elegans </i>proteins (Wormpep)</td><td>8457</td><td>345</td><td>280</td></tr><tr><td><i>S. mansoni </i>proteins</td><td>3440</td><td>598</td><td>419</td></tr><tr><td>Human proteins</td><td>4539</td><td>408... | <table><tr><td>Dataset</td><td>Nematode hits</td><td>Trematode hits</td><td>Cestode hits</td></tr><tr><td>C. elegans proteins (Wormpep)</td><td>8457</td><td>345</td><td>280</td></tr><tr><td>S. mansoni proteins</td><td>3440</td><td>598</td><td>419</td></tr><tr><td>Human proteins</td><td>4539</td><td>408</td><td>326</td>... | <table><tr><td>atabase</td><td>6</td><td></td><td></td></tr><tr><td>S. japonicum proteins</td><td>3456</td><td>612</td><td>416</td></tr></table> |
39462305c108655fc7de9e8950594a52417cfcdc39122c472519f1367636e3fd.png | complex | <table><tr><td>Variables</td><td></td><td>Frequency</td><td>Percent</td></tr><tr><td rowspan="2">Abdomen palpated to rule out the presence of second baby</td><td>Yes</td><td>331</td><td>62.7</td></tr><tr><td>No</td><td>197</td><td>37.3</td></tr><tr><td rowspan="4">Uterotonic drugs given</td><td>Oxytocin</td><td>432</td... | <table><tr><td>Variables</td><td></td><td>Frequency</td><td>Percent</td></tr><tr><td rowspan="2">Abdomen palpated to rule out the presence of second baby</td><td>Yes</td><td>331</td><td>62.7</td></tr><tr><td>No</td><td>197</td><td>37.3</td></tr><tr><td rowspan="4">Uterotonic drugs given</td><td>Oxytocin</td><td>432</td... | <table><tr><td>Dose of uterotonic drugs given</td><td>Others</td><td>6</td><td>1.1</td></tr><tr><td rowspan="3">Route of uterotonic drugs given</td><td>IM</td><td>519</td><td>97.2</td></tr><tr><td>IV</td><td>9</td><td>1.7</td></tr><tr><td>Oral</td><td>6</td><td>1.1</td></tr><tr><td rowspan="2">Wait uterine contraction ... |
a35c170936ee5639cea34c5d5c562b3ed537c55511a61e66e199aa39b4dd3d4b.png | complex | <table><tr><td>Cutoff</td><td>Results</td><td>African population<i>N</i> (%)</td><td>Caucasian population<i>N</i> (%)</td><td><i>p</i></td></tr><tr><td rowspan="2">AR ≥ 1%</td><td>Negative</td><td>22 (33.8)</td><td>22 (16.9)</td><td></td></tr><tr><td>Positive</td><td>43 (66.2)</td><td>108 (83.1)</td><td>0.008</td... | <table><tr><td>Cutoff</td><td>Results</td><td>African populationN (%)</td><td>Caucasian populationN (%)</td><td>p</td></tr></table> | <table><tr><td rowspan="2">AR ≥ 1%</td><td>Negative</td><td>22 (33.8)</td><td>22 (16.9)</td><td></td></tr><tr><td>Positive</td><td>43 (66.2)</td><td>108 (83.1)</td><td>0.008</td></tr><tr><td rowspan="2">AR ≥ 10%</td><td>Negative</td><td>25 (38.5)</td><td>27 (20.8)</td><td></td></tr><tr><td>Positive</td><td>40 (61.5)</t... |
79cbc6e09c3de35e399ac3fd8dc9312ef2ebfc25e2e63ec1c7c60d426dcec33f.png | simple | <table><tr><td>Species</td><td>Title of publication</td><td>cDNAs used for reprogramming</td><td>Origin of cDNAs</td></tr><tr><td>Rhesus macaque (<i>Macaca mulatta</i>)</td><td>Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts [24]</td><td><i>POU5F1, SOX2 KLF4</i> and <i>MYC </i></td><td... | <table><tr><td>Species</td><td>Title of publication</td><td>cDNAs used for reprogramming</td><td>Origin of cDNAs</td></tr><tr><td>Rhesus macaque (Macaca mulatta)</td><td>Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts [24]</td><td>POU5F1, SOX2 KLF4 and MYC</td><td>Rhesus</td></tr><tr><... | <table><tr><td>Pigtailed macaque (Macaca nemestrina)</td><td>Efficient generation of nonhuman primate induced pluripotent stem cells [28]</td><td>POU5F1, SOX2 KLF4 and MYC</td><td>Human</td></tr><tr><td>Cynomolgus monkey (Macaca fascicularis)</td><td>Development of histocompatible primate induced pluripotent stem cells... |
7cc8a2688bb7dd9b857025034048d4a4965777d0d6725017be0c2ffaf6aca49e.png | simple | <table><tr><td>Age</td><td>Sex</td><td>Cause of death</td></tr><tr><td>60</td><td>F</td><td>Hemorrhagic stroke</td></tr><tr><td>56</td><td>F</td><td>Hemorrhagic stroke</td></tr><tr><td>25</td><td>M</td><td>Traumatic brain injury</td></tr><tr><td>40</td><td>F</td><td>Hemorrhagic stroke</td></tr><tr><td>50</td><td>F</td>... | <table><tr><td>Age</td><td>Sex</td><td>Cause of death</td></tr><tr><td>60</td><td>F</td><td>Hemorrhagic stroke</td></tr><tr><td>56</td><td>F</td><td>Hemorrhagic stroke</td></tr><tr><td>25</td><td>M</td><td>Traumatic brain injury</td></tr><tr><td>40</td><td>F</td><td>Hemorrhagic stroke</td></tr><tr><td>50</td><td>F</td>... | <table><tr><td>33</td><td>M</td><td>Traumatic brain injury</td></tr><tr><td>27</td><td>M</td><td>Traumatic brain injury</td></tr><tr><td>18</td><td>M</td><td>Traumatic brain injury</td></tr><tr><td>23</td><td>M</td><td>Traumatic brain injury</td></tr><tr><td>52</td><td>M</td><td>Hemorrhagic stroke</td></tr><tr><td>56</... |
ee8b4497dd2e6bb9c23550929b6e0cdb8522c4ce1ec218c5eb9c116dd1f7d508.png | complex | <table><tr><td></td><td>Respimat® 5 μg</td><td>HandiHaler® 18 μg</td><td>Placebo</td></tr><tr><td colspan="4">Average heart rate (BPM), mean ± SD (min–max)</td></tr><tr><td colspan="4"> <i>Study 205.284</i></td></tr><tr><td>Baseline</td><td>–</td><td>79.89 ± 10.88 (59–108... | <table><tr><td></td><td>Respimat® 5 μg</td><td>HandiHaler® 18 μg</td><td>Placebo</td></tr><tr><td colspan="4">Average heart rate (BPM), mean ± SD (min–max)</td></tr><tr><td colspan="4">Study 205.284</td></tr><tr><td>Baseline</td><td>–</td><td>79.89 ± 10.88 (59–108)</td><td>81.35 ± 9.14 (52–97)</td></tr><tr><td>Day 84</... | <table><tr><td colspan="4">Studies 205.254/255</td></tr><tr><td>Baseline</td><td>2/121 (1.7)</td><td>–</td><td>3/109 (2.8)</td></tr><tr><td>Day 281</td><td>1/103 (1.0)</td><td>–</td><td>2/73 (2.7)</td></tr><tr><td colspan="4">Study 205.458</td></tr><tr><td>Day 26</td><td>0</td><td>1/113 (0.9)</td><td>0</td></tr><tr><td... |
b1b9d46699a492b115a349ee3a417f9686f3494723449b188b3224d3442f40ca.png | complex | <table><tr><td>Predictor</td><td><i>B</i></td><td><i>SE</i></td><td><i>t</i></td></tr><tr><td colspan="4">MEDIATOR—PERCEPTIONS OF INJUSTICE</td></tr><tr><td>Control: Negative affectivity</td><td>0.13</td><td>0.02</td><td>8.27<sup>***</sup></td></tr><tr><td>Predictor: Observed incivility toward women</td><td>0.61<... | <table><tr><td>Predictor</td><td>B</td><td>SE</td><td>t</td></tr><tr><td colspan="4">MEDIATOR—PERCEPTIONS OF INJUSTICE</td></tr><tr><td>Control: Negative affectivity</td><td>0.13</td><td>0.02</td><td>8.27***</td></tr><tr><td>Predictor: Observed incivility toward women</td><td>0.61</td><td>0.04</td><td>17.51***</td></tr... | <table><tr><td>Interaction: Observed Incivility × Observer Gender</td><td>0.09</td><td>0.04</td><td>2.50*</td></tr><tr><td colspan="4">OUTCOME—PERCEPTIONS OF SAFETY</td></tr><tr><td>Control: Negative affectivity</td><td>−0.19</td><td>0.03</td><td>−6.25***</td></tr><tr><td>Mediator: Perceptions of injustice</td><td>−0.1... |
f4703a7cc0a64e9bbf758c31560b7070c9cff8d37f8cd788c0ee07b0976efeea.png | complex | <table><tr><td>Rat strains</td><td colspan="2">WKY</td><td colspan="2">SHR</td><td colspan="2">SHRSP5/Dmcr</td></tr><tr><td></td><td>Control</td><td>HFC</td><td>Control</td><td>HFC</td><td>Control</td><td>HFC</td></tr><tr><td>Body weight (g)</td><td>365 ± 22.6</td><td>331 ± 7.8 <sup>a</sup></td><td>339 ±... | <table><tr><td>Rat s</td><td colspan="2">WK</td><td colspan="2"></td><td colspan="2">SHRS</td></tr></table> | <table><tr><td>trains</td><td colspan="2">Y</td><td colspan="2">SHR</td><td colspan="2">P5/Dmcr</td></tr><tr><td></td><td>Control</td><td>HFC</td><td>Control</td><td>HFC</td><td>Control</td><td>HFC</td></tr><tr><td>Body weight (g)</td><td>365 ± 22.6</td><td>331 ± 7.8 a</td><td>339 ± 14.5</td><td>301 ± 10.8 a</td><td>28... |
e989b33c4d13f94d02434bbc584f3373a99944eb02acfdd65938e923f21da48f.png | simple | <table><tr><td>Source</td><td>Patients</td><td>Inclusion criteria</td><td>Antioxidant agent</td><td>Dose</td><td>Route</td><td>Endpoints</td><td>Followup</td><td>Events</td></tr><tr><td>CHAOS [106]</td><td>2002</td><td>Angiographically demonstrated CAD</td><td>Vit E</td><td>400/800 IU</td><td>PO</td><td>CV death + MI; ... | <table><tr><td>Source</td><td>Patients</td><td>Inclusion criteria</td><td>Antioxidant agent</td><td>Dose</td><td>Route</td><td>Endpoints</td><td>Followup</td><td>Events</td></tr><tr><td>CHAOS [106]</td><td>2002</td><td>Angiographically demonstrated CAD</td><td>Vit E</td><td>400/800 IU</td><td>PO</td><td>CV death + MI; ... | <table><tr><td>Source</td><td>Patients</td><td>Inclusion criteria</td><td>Antioxidant agent</td><td>Dose</td><td>Route</td><td>Endpoints</td><td>Followup</td><td>Events</td></tr><tr><td>[108]</td><td></td><td>ialysis CV disease pts</td><td></td><td>U</td><td>PO</td><td>(MI, ACS, PAD, and stroke)</td><td></td><td></td><... |
3deb7c19e964369795e70997cf9c0332ca2acab34ec1e63d834fa62a5b978d89.png | simple | <table><tr><td>Language version ofsurvey</td><td>Responses</td></tr><tr><td>English</td><td>17785</td></tr><tr><td>Spanish</td><td>1052</td></tr><tr><td>French</td><td>955</td></tr><tr><td>Russian</td><td>330</td></tr><tr><td>Chinese</td><td>265</td></tr><tr><td>Japanese</td><td>258</td></tr><tr><td>Arabic</td><td>18</... | <table><tr><td>Language version ofsurvey</td><td>Responses</td></tr><tr><td>English</td><td>17785</td></tr><tr><td>Spanish</td><td>1052</td></tr></table> | <table><tr><td>French</td><td>955</td></tr><tr><td>Russian</td><td>330</td></tr><tr><td>Chinese</td><td>265</td></tr><tr><td>Japanese</td><td>258</td></tr><tr><td>Arabic</td><td>18</td></tr><tr><td>Total</td><td>20663</td></tr></table> |
8d1e0a5834a586ff841c9b7f54c845c82766fb2a168fee98bd55c418ac9dcdd7.png | simple | <table><tr><td> </td><td>Correlation coefficient (<i>r</i>)</td><td><i>P</i> value</td></tr><tr><td>Tissue estriol-tissue OxLDL</td><td>0.36</td><td> 0.004</td></tr><tr><td>Tissue estriol-GW</td><td>0.25</td><td> >0.05</td></tr><tr><td>Tissue OxLDL-GW</td><td>0.04</td><td> >0.05</td></tr><tr><td>Tissue estriol-in... | <table><tr><td></td><td>Correlation coefficient (r)</td><td>P value</td></tr></table> | <table><tr><td>Tissue estriol-tissue OxLDL</td><td>0.36</td><td>0.004</td></tr><tr><td>Tissue estriol-GW</td><td>0.25</td><td>>0.05</td></tr><tr><td>Tissue OxLDL-GW</td><td>0.04</td><td>>0.05</td></tr><tr><td>Tissue estriol-infant's birth weight</td><td>0.39</td><td>0.002</td></tr><tr><td>Tissue estriol-systolic BP</td... |
0bbfc63d1bae84c537315c893d7afae66d3d90af5e9c4d6e5b3c88a0cec21754.png | simple | <table><tr><td>Strain No.</td><td>SGSC No.</td><td>PCR results</td></tr><tr><td>RKS4587</td><td>2289</td><td>-</td></tr><tr><td>RKS4620</td><td>2291</td><td>-</td></tr><tr><td>33K</td><td>2419</td><td>-</td></tr><tr><td>CN13/87</td><td>2712</td><td>-</td></tr><tr><td>RKS4585</td><td>2998</td><td>+</td></tr><tr><td>RKS4... | <table><tr><td>Strain No.</td><td>SGSC No.</td><td>PCR results</td></tr></table> | <table><tr><td>RKS4587</td><td>2289</td><td>-</td></tr><tr><td>RKS4620</td><td>2291</td><td>-</td></tr><tr><td>33K</td><td>2419</td><td>-</td></tr><tr><td>CN13/87</td><td>2712</td><td>-</td></tr><tr><td>RKS4585</td><td>2998</td><td>+</td></tr><tr><td>RKS4586</td><td>2999</td><td>+</td></tr><tr><td>RKS4588</td><td>3000<... |
cd0a8b8a02756338c1c1c3595927cc59ddc51f433d191580569cdedbc7baec0b.png | simple | <table><tr><td>Variable</td><td>N</td><td>Median</td><td>Mean</td><td>SD</td></tr><tr><td>Programs offering residential treatment*</td><td></td><td></td><td></td><td></td></tr><tr><td> Average daily client census</td><td>49</td><td>26.0</td><td>43.4</td><td>59.0</td></tr><tr><td> Client occupancy ratio (%)<sup>†<... | <table><tr><td>Variable</td><td>N</td><td>Median</td><td>Mean</td><td>SD</td></tr><tr><td>Programs offering residential treatment*</td><td></td><td></td><td></td><td></td></tr><tr><td>Average daily client census</td><td>49</td><td>26.0</td><td>43.4</td><td>59.0</td></tr><tr><td>Client occupancy ratio (%)†</td><td>49</t... | <table><tr><td>Average length of stay (days)</td><td>47</td><td>96.0</td><td>118.8</td><td>92.8</td></tr><tr><td>Daily residential reimbursement ($)</td><td>38</td><td>183.00</td><td>200.92</td><td>99.72</td></tr><tr><td>Quality Score#</td><td>78</td><td>15.0</td><td>14.6</td><td>1.6</td></tr><tr><td>Programs offering ... |
eb4559f6bc6bdc028cc6f336dd0e6abe81ffe2868bf47785b81cecd0ef91e746.png | simple | <table><tr><td>Subject No.<sup>a</sup></td><td>Sex (age)<sup>c</sup></td><td>CD4 Count (cells/μl)</td><td>CD8 Count (cells/μl)</td><td>Plasma Viral Load (copies/ml)</td><td>HCV<sup>b</sup></td><td>HBV<sup>b</sup></td><td>HIV Subtype</td></tr><tr><td>1</td><td>M(42)</td><td>332</td><td>1326</td><td>18800</td><... | <table><tr><td>Subject No.a</td><td>Sex (age)c</td><td>CD4 Count (cells/μl)</td><td>CD8 Count (cells/μl)</td><td>Plasma Viral Load (copies/ml)</td><td>HCVb</td><td>HBVb</td><td>HIV Subtype</td></tr><tr><td>1</td><td>M(4</td><td></td><td>1326</td><td>18</td><td>P</td><td></td><td></td></tr></table> | <table><tr><td></td><td>2)</td><td>332</td><td></td><td>800</td><td></td><td>P</td><td>CRF07-BC</td></tr><tr><td>2</td><td>F(38)</td><td>412</td><td>1373</td><td>92300</td><td>N</td><td>N</td><td>CRF01-AE</td></tr><tr><td>3</td><td>M(45)</td><td>368</td><td>463</td><td>71000</td><td>P</td><td>N</td><td>B</td></tr><tr><... |
199b093abc2020d4a9729cd553070b6f0e10493b2215a02e2486a86b1860130b.png | complex | <table><tr><td rowspan="2">COX4 Expression</td><td colspan="4">Hsp60 Expression</td><td rowspan="2">Total, N</td></tr><tr><td>-</td><td>+</td><td>++</td><td>+++</td></tr><tr><td>-</td><td>11</td><td>15</td><td>5</td><td>0</td><td>31</td></tr><tr><td>+</td><td>8</td><td>36</td><td>29</td><td>37</td><td>110</td></tr><tr>... | <table><tr><td rowspan="2">COX4 Expression</td><td colspan="4">Hsp60 Expression</td><td rowspan="2">Total, N</td></tr><tr><td>-</td><td>+</td><td>++</td><td>+++</td></tr><tr><td></td><td>1</td><td>15</td><td>5</td><td></td><td>3</td></tr></table> | <table><tr><td>-</td><td>1</td><td></td><td></td><td>0</td><td>1</td></tr><tr><td>+</td><td>8</td><td>36</td><td>29</td><td>37</td><td>110</td></tr><tr><td>++</td><td>4</td><td>17</td><td>12</td><td>31</td><td>64</td></tr><tr><td>+++</td><td>3</td><td>15</td><td>11</td><td>41</td><td>70</td></tr><tr><td>Total, N</td><t... |
cdda26b1942494e93a9ea6c8abf238575afd0ffe52da0cce26e1bc13b6926673.png | simple | <table><tr><td>Name</td><td>Fold Change (T/N)</td><td>log2Fold Change(T/N)</td><td><i>P</i> Value</td><td>FDR</td></tr><tr><td>hsa-mir-210</td><td>31.74</td><td>4.99</td><td>2.54E-05</td><td>0.004</td></tr><tr><td>hsa-mir-183</td><td>7.22</td><td>2.85</td><td>6.03E-05</td><td>0.007</td></tr><tr><td>hsa-mir-10b</td><td>... | <table><tr><td>Name</td><td>Fold Change (T/N)</td><td>log2Fold Change(T/N)</td></tr><tr><td>hsa-mir-210</td><td>31.74</td><td>4.99</td></tr><tr><td>hsa-mir-183</td><td>7.22</td><td>2.85</td></tr><tr><td>hsa-mir-10b</td><td>0.34</td><td>−1.55</td></tr><tr><td>hsa-mir-100</td><td>0.25</td><td>−2.02</td></tr><tr><td>hsa-m... | <table><tr><td>P Value</td><td>FDR</td></tr><tr><td>2.54E-05</td><td>0.004</td></tr><tr><td>6.03E-05</td><td>0.007</td></tr><tr><td>0.00037</td><td>0.026</td></tr><tr><td>1.47E-05</td><td>0.003</td></tr><tr><td>6.49E-09</td><td>0.000</td></tr><tr><td>3.6E-06</td><td>0.001</td></tr><tr><td>7.75E-06</td><td>0.002</td></t... |
83b1e00b645689b658a2e7d8746378c183c7b6eb51c440b577b1d2093712b649.png | complex | <table><tr><td>MMCO Metrics</td><td>Metrics Detail</td><td>MMCO V2.0 (Existing Work) [6]</td><td>MMCO V3.0 (Extended Work)</td></tr><tr><td rowspan="8">Metrics</td><td>Axioms</td><td>793</td><td>1092</td></tr><tr><td>Logical Axioms</td><td>624</td><td>859</td></tr><tr><td>Class count</td><td>45</td><td>225</td></tr><tr... | <table><tr><td>MMCO Metrics</td><td>Metrics Detail</td><td>MMCO V2.0 (Existing Work) [6]</td><td>MMCO V3.0 (Extended Work)</td></tr><tr><td rowspan="6">Metrics</td><td>Axioms</td><td>793</td><td>1092</td></tr><tr><td>Logical Axioms</td><td>624</td><td>859</td></tr><tr><td>Class count</td><td>45</td><td>225</td></tr><tr... | <table><tr><td rowspan="2">Metrics</td><td>Asserted Triples</td><td>0</td><td>3312</td></tr><tr><td>Inferred Triples</td><td>0</td><td>6041</td></tr><tr><td rowspan="3">Class Axioms</td><td>SubClassOf</td><td>32</td><td>222</td></tr><tr><td>Equivalent Classes</td><td>9</td><td>17</td></tr><tr><td>Disjoint Classes</td><... |
53bce9d71952b908921878f063b7cd1937091240a9efeac9739d6a32610b4533.png | simple | <table><tr><td>Variables</td><td>Pretraining</td><td>Posttraining</td><td>t</td><td>p</td></tr><tr><td>Basic rhythm (left)</td><td>74.23 ± 6.84</td><td>75.07 ± 9.04</td><td>−0.189</td><td>0.856</td></tr><tr><td>Basic rhythm (right)</td><td>75.40 ± 9.70</td><td>72.85 ± 10.20</td><td>0.363</td><... | <table><tr><td>Variables</td><td>Pretraining</td><td>Posttraining</td><td>t</td><td>p</td></tr></table> | <table><tr><td>Basic rhythm (left)</td><td>74.23 ± 6.84</td><td>75.07 ± 9.04</td><td>−0.189</td><td>0.856</td></tr><tr><td>Basic rhythm (right)</td><td>75.40 ± 9.70</td><td>72.85 ± 10.20</td><td>0.363</td><td>0.729</td></tr><tr><td>Self-control index</td><td>48.47 ± 14.28</td><td>51.93 ± 13.50</td><td>−0.393</td><td>0.... |
551318c979d7522f8ecce068f116bd8e13a36a4fc1d6bc5259b2c416978dacd9.png | complex | <table><tr><td colspan="6">Canagliflozin (300 mg q.d.) and cyclosporine A (400 mg q.d.)</td></tr><tr><td rowspan="2">Parameter</td><td colspan="2">Arithmetic mean (SD)</td><td colspan="3">Geometric mean<sup>a</sup></td></tr><tr><td>Canagliflozin alone (n = 18)</td><td>Canagliflozin + cyclosporine A (n = 17)</td><td>Can... | <table><tr><td colspan="6">Canagliflozin (300 mg q.d.) and cyclosporine A (400 mg q.d.)</td></tr></table> | <table><tr><td rowspan="2">Parameter</td><td colspan="2">Arithmetic mean (SD)</td><td colspan="3">Geometric meana</td></tr><tr><td>Canagliflozin alone (n = 18)</td><td>Canagliflozin + cyclosporine A (n = 17)</td><td>Canagliflozin alone (reference) (n = 17)</td><td>Canagliflozin + cyclosporine A (test) (n = 17)</td><td>... |
bd15bddfba32369388463b73fa493572c355105ad57887674bf996eaf5e5a7bb.png | complex | <table><tr><td>Collection Season</td><td colspan="4">District</td></tr><tr><td></td><td>Pampulha</td><td>North</td><td>East</td><td>All districts</td></tr><tr><td></td><td>IF/CF (IR%)</td><td>IF/CF (IR%)</td><td>IF/CF (IR%)</td><td>IF/CF (IR%)</td></tr><tr><td>1st</td><td>14/67 (20.8)</td><td>9/22 (40.9)</td><td>3/28 (... | <table><tr><td>Collection Season</td><td colspan="4">District</td></tr></table> | <table><tr><td></td><td>Pampulha</td><td>North</td><td>East</td><td>All districts</td></tr><tr><td></td><td>IF/CF (IR%)</td><td>IF/CF (IR%)</td><td>IF/CF (IR%)</td><td>IF/CF (IR%)</td></tr><tr><td>1st</td><td>14/67 (20.8)</td><td>9/22 (40.9)</td><td>3/28 (10.7)</td><td>26/117 (22.2)</td></tr><tr><td>2nd</td><td>15/17 (... |
ae56985ca37a236e3f20856824981db67dab10e2a0e299b496e8ef4279204b28.png | complex | <table><tr><td rowspan="2">Variables</td><td colspan="2">Diarrhoea</td><td colspan="2">Fever</td><td colspan="2">Cough</td></tr><tr><td>COR</td><td>AOR</td><td>COR</td><td>AOR</td><td>COR</td><td>AOR</td></tr><tr><td>Toilet facilities (yes)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>No</td><... | <table><tr><td rowspan="2">Variables</td><td colspan="2">Diarrhoea</td><td colspan="2">Fever</td><td colspan="2">Cough</td></tr><tr><td>COR</td><td>AOR</td><td>COR</td><td>AOR</td><td>COR</td><td>AOR</td></tr><tr><td>Toilet facilities (yes)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>No</td><... | <table><tr><td>Toilet + water + disposal facilities (yes)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>No</td><td>1.137 (0.968–1.336)</td><td>1.329(1.046–1.947)</td><td>1.180 (0.568–2.449)</td><td>1.242(1.050–1.468)</td><td>1.220(1.050–1.418)</td><td>1.432(1.113–2.902)</td></tr></table> |
a1e8f4e48b1d6f7fa511e41f06e210a0de145bc2771dd4da243f9f3af2138794.png | simple | <table><tr><td>Factor</td><td>HR</td><td>95 % confidence interval</td><td>P value</td></tr><tr><td>Acute kidney injury 3</td><td>7.35</td><td>2.15–25.07</td><td>0.001</td></tr><tr><td>Peripheral vascular disease</td><td>1.95</td><td>1.12–3.39</td><td>0.019</td></tr><tr><td>Chronic renal failure</td><td>1.59... | <table><tr><td>Factor</td><td>HR</td><td>95 % confidence interval</td><td>P value</td></tr><tr><td>Acute kidney injury 3</td><td>7.35</td><td>2.15–25.07</td><td>0.001</td></tr></table> | <table><tr><td>Factor</td><td>HR</td><td>95 % confidence interval</td><td>P value</td></tr><tr><td>Peripheral vascular disease</td><td>1.95</td><td>1.12–3.39</td><td>0.019</td></tr><tr><td>Chronic renal failure</td><td>1.59</td><td>0.96–2.62</td><td>0.07</td></tr><tr><td>Diabetes mellitus</td><td>0.83</td><td>0.49–1.40... |
21cdf96cca7f5cf2074c7ce56d8c46cea207b6a921b75d333e8f2d6ec7c710cd.png | complex | <table><tr><td></td><td colspan="2">MIC (μg/mL)</td></tr><tr><td>Formulation</td><td>MS-Lac</td><td>Estimated Gentamicin in Microspheres *</td></tr><tr><td>MS-Lac1</td><td>2.16</td><td>0.31</td></tr><tr><td>MS-Lac2</td><td>2.92</td><td>0.31</td></tr><tr><td>MS-Lac3</td><td>4.00</td><td>0.31</td></tr></table> | <table><tr><td></td></tr><tr><td>Formulation</td></tr><tr><td>MS-Lac1</td></tr><tr><td>MS-Lac2</td></tr><tr><td>MS-Lac3</td></tr></table> | <table><tr><td colspan="2">MIC (μg/mL)</td></tr><tr><td>MS-Lac</td><td>Estimated Gentamicin in Microspheres *</td></tr><tr><td>2.16</td><td>0.31</td></tr><tr><td>2.92</td><td>0.31</td></tr><tr><td>4.00</td><td>0.31</td></tr></table> |
538e9ee5f34c3224c2631be90703d75b1e8baa105cf4934e53f70627adeb4779.png | complex | <table><tr><td>Variable</td><td>Adjusted PR (95%CI)</td><td><i>p</i>-value<sup>a</sup></td></tr><tr><td colspan="3"><i>Housing area</i></td></tr><tr><td>Urban</td><td>1</td><td> </td></tr><tr><td>Rural</td><td>1.15 (1.0-1.3)</td><td>0.030</td></tr><tr><td colspan="3"> </td></tr><tr><td colspan="3"><i>School type</i></t... | <table><tr><td>Variable</td><td>Adjusted PR (95%CI)</td><td>p-valuea</td></tr><tr><td colspan="3">Housing area</td></tr><tr><td>Urban</td><td>1</td><td></td></tr><tr><td>Rural</td><td>1.15 (1.0-1.3)</td><td>0.030</td></tr><tr><td colspan="3"></td></tr><tr><td colspan="3">School type</td></tr><tr><td>Municipal</td><td>3... | <table><tr><td>Sometimes</td><td>0.80 (0.7-0.9)</td><td>0.003</td></tr><tr><td>Never</td><td>1</td><td></td></tr></table> |
fd336328d6f03c11a80f820469e8165b1983af5c8b2d888a312cc09e6ad16bea.png | simple | <table><tr><td>Clinicopathological parameters</td><td>Relative risk ( 95%CI)</td><td>p value</td></tr><tr><td>Age(≥65years)</td><td>0.884(0.561-1.395)</td><td>0.597</td></tr><tr><td>Sex(Female)</td><td>0.817(0.520-1.283)</td><td>0.380</td></tr><tr><td>Depth of invasion (T<sub>2-4</sub>)</td><td>5.873(2.058-16.762... | <table><tr><td>Clinicopathological parameters</td><td>Relative risk ( 95%CI)</td><td>p value</td></tr><tr><td>Age(≥65years)</td><td>0.884(0.561-1.395)</td><td>0.597</td></tr><tr><td>Sex(Female)</td><td>0.817(0.520-1.283)</td><td>0.380</td></tr><tr><td>Depth of invasion (T2-4)</td><td>5.873(2.058-16.762)</td><td>0.001</... | <table><tr><td>Clinicopathological parameters</td><td>Relative risk ( 95%CI)</td><td>p value</td></tr><tr><td>n(+)</td><td>29)</td><td>7</td></tr><tr><td>Venous invasion(+)</td><td>1.088(0.646-1.830)</td><td>0.752</td></tr><tr><td>Lymph node metastasis(+)</td><td>1.638(0.482-5.568)</td><td>0.429</td></tr><tr><td>Liver ... |
dde9f88a0e9195e24ecc376f6197f8585bdd12c75cc7d8d9712c84b1bce37bba.png | simple | <table><tr><td>Variable</td><td>Patients (%)</td></tr><tr><td>Gender</td><td></td></tr><tr><td> Male</td><td>74 (71.8)</td></tr><tr><td> Female</td><td>29 (28.2)</td></tr><tr><td>Age (y)</td><td></td></tr><tr><td> Mean</td><td>58.3</td></tr><tr><td> Range</td><td>26–75</td></tr><tr><td>Tumor location</td><td></td... | <table><tr><td>Variable</td><td>Patients (%)</td></tr><tr><td>Gender</td><td></td></tr><tr><td>Male</td><td>74 (71.8)</td></tr><tr><td>F</td><td>29 </td></tr></table> | <table><tr><td>emale</td><td>(28.2)</td></tr><tr><td>Age (y)</td><td></td></tr><tr><td>Mean</td><td>58.3</td></tr><tr><td>Range</td><td>26–75</td></tr><tr><td>Tumor location</td><td></td></tr><tr><td>EGJ</td><td>41 (39.8)</td></tr><tr><td>Body</td><td>27 (26.2)</td></tr><tr><td>Antrum</td><td>35 (34.0)</td></tr><tr><td... |
8c509a01a9e2d7b09f2a6925bda74a6e9f33214a63eb8e54ff0eec4ea593b890.png | simple | <table><tr><td>Patients</td><td>n = 3191</td></tr><tr><td>Age, years</td><td>70 ± 10</td></tr><tr><td>≤65 years, %</td><td>30</td></tr><tr><td>66-79 years, %</td><td>54</td></tr><tr><td>≥80 years, %</td><td>16</td></tr><tr><td>Gender, male vs. female, %</td><td>43 vs. 57</td></tr><tr><td>BMI, kg/m<sup>... | <table><tr><td>Patients</td></tr><tr><td>Age, years</td></tr><tr><td>≤65 years, %</td></tr><tr><td>66-79 years, %</td></tr><tr><td>≥80 years, %</td></tr><tr><td>Gender, male vs. female, %</td></tr><tr><td>BMI, kg/m2</td></tr><tr><td>SBP at entry, mmHg</td></tr><tr><td>Uncontrolled SBP (≥140 mmHg) at entry, %</td></tr><... | <table><tr><td>n = 3191</td></tr><tr><td>70 ± 10</td></tr><tr><td>30</td></tr><tr><td>54</td></tr><tr><td>16</td></tr><tr><td>43 vs. 57</td></tr><tr><td>23 ± 3</td></tr><tr><td>147 ± 17</td></tr><tr><td>66</td></tr><tr><td>83 ± 11</td></tr><tr><td>37</td></tr><tr><td>68</td></tr><tr><td>32</td></tr><tr><td>12</td></tr>... |
6eb37bfbc5d49bf05046c90b57d73a9e4113a5377a6895addcea67ccc356b506.png | simple | <table><tr><td> </td><td>Progression-free survival</td><td>Overall survival</td></tr><tr><td>AUC (95% CIs)</td><td>0.71 (0.57–0.83)</td><td>0.65 (0.50–0.78)</td></tr><tr><td>Criterion (cut-off)</td><td>≥19%</td><td>≥13%</td></tr><tr><td>Sensitivity</td><td>73%</td><td>58%</td></tr><tr><td>Specif... | <table><tr><td></td><td>Progression-free survival</td></tr><tr><td>AUC (95% CIs)</td><td>0.71 (0.57–0.83)</td></tr><tr><td>Criterion (cut-off)</td><td>≥19%</td></tr><tr><td>Sensitivity</td><td>73%</td></tr><tr><td>Specificity</td><td>77%</td></tr><tr><td>p value</td><td>0.0054</td></tr></table> | <table><tr><td>Overall survival</td></tr><tr><td>0.65 (0.50–0.78)</td></tr><tr><td>≥13%</td></tr><tr><td>58%</td></tr><tr><td>70%</td></tr><tr><td>0.057</td></tr></table> |
d7b950d8e878af7b386e539fd036b4ba778120703c992f7889a28e3d8fdcb2c4.png | complex | <table><tr><td rowspan="3">Run</td><td colspan="6">Parameters</td><td colspan="2">HPR (ml H<sub>2</sub>/L h)</td></tr><tr><td colspan="2">Initial pH (<i>X</i><sub>1</sub>)</td><td colspan="2">Light intensity (<i>X</i><sub>2</sub>)</td><td colspan="2">Mo concentration (<i>X</i><sub>3</sub>)</td><td rowspan="2">Observed<... | <table><tr><td rowspan="3">Run</td><td colspan="6">Parameters</td><td colspan="2">HPR (ml H2/L h)</td></tr><tr><td colspan="2">Initial pH (X1)</td><td colspan="2">Light intensity (X2)</td><td colspan="2">Mo concentration (X3)</td><td rowspan="2">Observed</td><td rowspan="2">Predicted</td></tr><tr><td>Code</td><td>Actua... | <table><tr><td>6</td><td>0.00</td><td>8.00</td><td>−1.68</td><td>4.64</td><td>0.00</td><td>0.30</td><td>5.8 ± 0.4</td><td>6.5</td></tr><tr><td>7</td><td>0.00</td><td>8.00</td><td>0.00</td><td>8.00</td><td>0.00</td><td>0.30</td><td>8.8 ± 0.3</td><td>8.8</td></tr><tr><td>8</td><td>1.00</td><td>9.00</td><td>−1.00</td><td>... |
0d8680db68e2ae7a7cc371c929b7e27e8a32b9dc5c4a34b0da54c97624aeeea2.png | complex | <table><tr><td>Patient characteristics</td><td>Value</td></tr><tr><td>Age (years), median (IQR)</td><td>38.0 (29.0–43.0)</td></tr><tr><td colspan="2">Sex, <i>n</i> (%)</td></tr><tr><td> Female</td><td>13 (68.4)</td></tr><tr><td> Male</td><td>6 (31.6)</td></tr><tr><td colspan="2">Race, <i>n</i> (%)</td></tr><tr><t... | <table><tr><td>Patient characteristics</td><td>Value</td></tr><tr><td>Age (years), median (IQR)</td><td>38.0 (29.0–43.0)</td></tr><tr><td colspan="2">Sex, n (%)</td></tr><tr><td>Female</td><td>13 (68.4)</td></tr><tr><td>Male</td><td>6 (31.6)</td></tr><tr><td colspan="2">Race, n (%)</td></tr><tr><td>White</td><td>19 (10... | <table><tr><td>Renal AML</td><td>19 (100)</td></tr><tr><td>Facial angiofibromas/forehead plaque</td><td>15 (79.0)</td></tr><tr><td>Cortical tuber</td><td>10 (52.6)</td></tr><tr><td>Hypomelanotic macules (≥3)</td><td>7 (36.8)</td></tr><tr><td>Subependymal nodule</td><td>7 (36.8)</td></tr><tr><td>Non-traumatic ungual/per... |
f0958074927e3ed747b9ae853e17889050f15ee24411412bf967f4f12acba006.png | complex | <table><tr><td></td><td colspan="5">Inpatient hospital contact (1987–2012)</td><td colspan="5">Any hospital contact (2001–2012)</td></tr><tr><td></td><td colspan="2">No bereavement</td><td colspan="3">Bereavement</td><td colspan="2">No bereavement</td><td colspan="3">Bereavement</td></tr><tr><td></td><td>N<... | <table><tr><td></td><td colspan="3">Inpatient hospital contact (1987–2012)</td></tr><tr><td></td><td colspan="2">No bereavement</td><td>Bereavement</td></tr><tr><td></td><td>N</td><td>Crude IR (100,000 PYs)</td><td>N</td></tr><tr><td>Any STI</td><td>5903</td><td>17.00</td><td>1188</td></tr><tr><td>Condyloma a</td><td>2... | <table><tr><td colspan="2">Inpatient hospital contact (1987–2012)</td><td colspan="5">Any hospital contact (2001–2012)</td></tr><tr><td colspan="2">Bereavement</td><td colspan="2">No bereavement</td><td colspan="3">Bereavement</td></tr><tr><td>Crude IR (100,000 PYs)</td><td>IRR (95 % CI)</td><td>N</td><td>Crude IR (100... |
1414d8411c051cc88e93471a16972aa5a39a7386744d6b346ec90c0095bd499b.png | simple | <table><tr><td>No.</td><td>IUPAC Name</td></tr><tr><td>BDE-209</td><td>Deca-bromodiphenyl ether</td></tr><tr><td>BDE-208</td><td>2,2',3,3',4,5,5',6, 6'- nona-bromodiphenyl ether</td></tr><tr><td>BDE-207</td><td>2,2',3,3',4,4',5,6,6'-nona-bromodiphenyl ether</td></tr><tr><td>BDE-206</td><td>2,2',3,3',4,4',5,5',6-nona-br... | <table><tr><td>No.</td></tr><tr><td>BDE-209</td></tr><tr><td>BDE-208</td></tr><tr><td>BDE-207</td></tr><tr><td>BDE-206</td></tr><tr><td>BDE-203</td></tr><tr><td>BDE-196</td></tr><tr><td>BDE-190</td></tr><tr><td>BDE-183</td></tr><tr><td>BDE-181</td></tr><tr><td>BDE-155</td></tr><tr><td>BDE-154</td></tr><tr><td>BDE-153</... | <table><tr><td>IUPAC Name</td></tr><tr><td>Deca-bromodiphenyl ether</td></tr><tr><td>2,2',3,3',4,5,5',6, 6'- nona-bromodiphenyl ether</td></tr><tr><td>2,2',3,3',4,4',5,6,6'-nona-bromodiphenyl ether</td></tr><tr><td>2,2',3,3',4,4',5,5',6-nona-bromodiphenyl ether</td></tr><tr><td>2,2',3,4,4',5,5',6-octa-bromodiphenyl eth... |
fb1505b0f1f1112c759282ec93397d63051e7b6a6e6f773270d7b8caad42eff8.png | simple | <table><tr><td></td><td>Appearance</td></tr><tr><td>Rich looking/smart/elegant</td><td>Liked the colors</td></tr><tr><td>Different</td><td>Simple/neat</td></tr><tr><td>Looks cold/refreshing/clean</td><td>Eye-catching/bold</td></tr><tr><td>Bright</td><td>Attractive</td></tr><tr><td>Happy</td><td>Modern and up-to-date</t... | <table><tr><td></td><td>Appearance</td></tr><tr><td>Rich looking/smart/elegant</td><td>Liked the colors</td></tr><tr><td>Different</td><td>Simple</td></tr></table> | <table><tr><td></td><td>Appearance</td></tr><tr><td></td><td>/neat</td></tr><tr><td>Looks cold/refreshing/clean</td><td>Eye-catching/bold</td></tr><tr><td>Bright</td><td>Attractive</td></tr><tr><td>Happy</td><td>Modern and up-to-date</td></tr><tr><td>Ordinary</td><td>Plain</td></tr><tr><td>Similar to others</td><td>Che... |
0d2354a290d68441aff09411f8a7b2de1a8b9bc9711cf8aec412a74598189839.png | simple | <table><tr><td>Variable</td><td>Baseline (2004)</td><td>5-year follow-up (2009)</td><td>P-value<sup>a</sup></td></tr><tr><td>Age, mean (SD)</td><td>43.6 (9.5)</td><td>48.6 (9.5)</td><td></td></tr><tr><td>SMBQ score, mean (SD)</td><td>2.86 (0.91)</td><td>2.71 (1.05)</td><td><0.001</td></tr><tr><td>SMBQ score > 4.0... | <table><tr><td>Variable</td><td>Baseline (2004)</td><td>5-year follow-up (2009)</td><td>P-valuea</td></tr><tr><td>Age, mean (SD)</td><td>43.6 (9.5)</td><td>48.6 (9.5)</td><td></td></tr><tr><td>SMBQ score, mean (SD)</td><td>2.86 (0.91)</td><td>2.71 (1.05)</td><td><0.001</td></tr><tr><td>SMBQ score > 4.0, N (%)</td><td>7... | <table><tr><td>Variable</td><td>Baseline (2004)</td><td>5-year follow-up (2009)</td><td>P-valuea</td></tr><tr><td>Satisfied</td><td>454/617 (73.6)</td><td>405/617 (65.6)</td><td></td></tr><tr><td>Dissatisfied</td><td>163/617 (26.4)</td><td>212/617 (34.4)</td><td><0.001</td></tr></table> |
7de9a028338bd4d9ddb838e0ccdf7b0302b0aaa73337a7efa6c358617d9ed598.png | complex | <table><tr><td></td><td colspan="3">Prior to 1:1 matching</td><td colspan="3">After 1:1 matching<sup>*</sup></td></tr><tr><td>Variables</td><td>Vulvar cancer patients</td><td>Controls</td><td><i>P</i>-value<sup>*</sup></td><td>Vulvar cancer patients</td><td>Controls</td><td><i>P</i>-value<sup>*</sup></td></tr><tr><td>N... | <table><tr><td></td><td colspan="3">Prior to 1:1 matching</td><td colspan="3">After 1:1 matching*</td></tr><tr><td>Variables</td><td>Vulvar cancer patients</td><td>Controls</td><td>P-value*</td><td>Vulvar cancer patients</td><td>Controls</td><td>P-value*</td></tr><tr><td>N</td><td>505</td><td>569,648</td><td></td><td>5... | <table><tr><td></td><td colspan="3">Prior to 1:1 matching</td><td colspan="3">After 1:1 matching*</td></tr><tr><td>Variables</td><td>Vulvar cancer patients</td><td>Controls</td><td>P-value*</td><td>Vulvar cancer patients</td><td>Controls</td><td>P-value*</td></tr><tr><td>Variables used for matched-pairs</td><td></td><t... |
ad96958877aba67ee3bf20beb974606fecc3f49a360be0dc9bd01b8efd28c4b7.png | simple | <table><tr><td></td><td>Arm A IRI+LV+5FU</td><td>Arm B LV+5FU</td><td><i>P </i>(log-rank)</td></tr><tr><td>Disease-free survival (DFS)</td><td></td><td></td><td>0.436</td></tr><tr><td> Progressions, <i>n (%)</i></td><td>110 (24.9)</td><td>112 (25.9)</td><td></td></tr><tr><td> Median (months)</td><td>Not reached yet</td... | <table><tr><td></td><td>Arm A IRI+LV+5FU</td><td>Arm B LV+5FU</td></tr><tr><td>Disease-free survival (DFS)</td><td></td><td></td></tr><tr><td>Progressions, n (%)</td><td>110 (24.9)</td><td>112 (25.9)</td></tr><tr><td>Median (months)</td><td>Not reached yet</td><td>Not reached yet</td></tr><tr><td>three-year DFS (%)</td... | <table><tr><td>P (log-rank)</td></tr><tr><td>0.436</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>0.334</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr></table> |
dda653adc92487b365e871ef74f69bdbef5c96192a74af8a7daadec8bc4c96b0.png | complex | <table><tr><td>Deliveries in six months</td><td colspan="2">Total number %</td><td colspan="2">Without malformation number %</td><td colspan="2">With malformation number %</td></tr><tr><td>Ayder referral hospital</td><td>503**</td><td>33</td><td>484</td><td>32</td><td>19</td><td>3.8</td></tr><tr><td>Mekelle hospital</t... | <table><tr><td>Deliveries in six months</td><td colspan="2">Total number %</td><td colspan="2">Without malformation number %</td><td colspan="2">With malformation number %</td></tr><tr><td>Ayder referral hospital</td><td>503**</td><td>33</td><td>484</td><td>32</td><td>19</td><td>3.8</td></tr><tr><td>Mekelle hospital</t... | <table><tr><td>Deliveries in six months</td><td colspan="2">Total number %</td><td colspan="2">Without malformation number %</td><td colspan="2">With malformation number %</td></tr><tr><td>LBW Female</td><td>448</td><td>30</td><td>438</td><td>98</td><td>10</td><td>2.2</td></tr><tr><td>VLBW</td><td>530</td><td>35</td><t... |
c70088f31f802d5f2fe232c57c2136f84c5fb2e22d2a288c625bd01684a662ba.png | simple | <table><tr><td></td><td>ypN0</td><td>ypN1</td><td>ypN2</td><td>Total</td></tr><tr><td>yN0</td><td>41</td><td>-</td><td>-</td><td>41 (66.1)</td></tr><tr><td>yN+</td><td>7</td><td>11</td><td>3</td><td>21 (33.9)</td></tr><tr><td>Total</td><td>48 (77.4)</td><td>11 (17.8)</td><td>3 (4.8)</td><td>62 (100)</td></tr></table> | <table><tr><td></td><td>ypN0</td><td>ypN1</td><td>ypN2</td></tr><tr><td>yN0</td><td>41</td><td>-</td><td>-</td></tr><tr><td>yN+</td><td>7</td><td>11</td><td>3</td></tr><tr><td>Total</td><td>48 (77.4)</td><td>11 (17.8)</td><td>3 (4.8)</td></tr></table> | <table><tr><td>Total</td></tr><tr><td>41 (66.1)</td></tr><tr><td>21 (33.9)</td></tr><tr><td>62 (100)</td></tr></table> |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.